Researchers Information System

日本語に切り替えるswitch to english

Matsui, Shigeyuki

Graduate School of Medicine, Public Health Professor

Matsui, Shigeyuki
list
    Last Updated :2026/08/21

    Basic Information

    Faculty

    • Faculty of Medicine

    Email Address

    • Email Address

      matsui.shigeyuki.5ykyoto-u.ac.jp

    Academic Degree

    • 20 Mar. 1993
      東京理科大学修士(工学)
    • 20 Mar. 1999
      東京理科大学博士(工学)

    Academic Resume (Graduate Schools)

    • 東京理科大学, 大学院工学研究科後期博士課程経営工学専攻, 修了
    • 東京理科大学, 大学院工学研究科博士後期課程経営工学専攻, 研究指導認定退学
    • 東京理科大学, 大学院工学研究科修士課程経営工学専攻, 修了

    Academic Resume (Undergraduate School/Majors)

    • 東京理科大学, 工学部第1部経営工学科, 卒業

    ID,URL

    researchmap URL

    list
      Last Updated :2026/08/21

      Research

      Research Areas

      • Natural sciences, Applied mathematics and statistics

      Papers

      • Rhythm-specific association of epinephrine with outcomes in non-shockable cardiac arrest: a nationwide propensity-matched study.
        Ryo Emoto; Mitsuaki Nishikimi; Kazuya Kikutani; Junki Ishii; Shinichiro Ohshimo; Shigeyuki Matsui; Nobuaki Shime; Taku Iwami
        Resuscitation, 30 Apr. 2026
      • Consciousness Disturbances Reported With Clindamycin Versus Cefazolin in Surgical Patients: A Global Pharmacovigilance Analysis Using VigiBase.
        Kazuki Nishida; Basile Chrétien; Hiroshi Morioka; Daigo Tamakoshi; Keita Hiraga; Tomoyuki Nakamura; Shigeyuki Matsui; Masahisa Katsuno; Yoshitaka Hara
        Clinical and translational science, Apr. 2026
      • Impact of post-decannulation high fever on mortality in patients with severe ARDS treated with veno-venous ECMO: a multicenter retrospective study.
        Kenji Fujizuka; Mitsuaki Nishikimi; Kazuya Kikutani; Ryo Emoto; Shinichiro Ohshimo; Shigeyuki Matsui; Nobuaki Shime; Hiroyuki Suzuki
        Journal of intensive care, 11 Feb. 2026
      • Positive ascites cytology in interval debulking surgery predicts poor outcomes of advanced epithelial ovarian cancer achieving complete tumor resection
        Marina Yoshikawa; Masato Yoshihara; Ryo Emoto; Shigeyuki Matsui; Hiroaki Kajiyama
        Scientific Reports, 10 Feb. 2026
      • Subphenotype-Specific Risk of Intracranial Hemorrhage During Extracorporeal Membrane Oxygenation in Acute Respiratory Distress Syndrome.
        Mitsuaki Nishikimi; Shinichiro Ohshimo; Wataru Fukumoto; Ryo Emoto; Kazuo Awai; Shigeyuki Matsui; Nobuaki Shime
        ASAIO journal (American Society for Artificial Internal Organs : 1992), 13 Jan. 2026
      • Neurological outcomes with hypothermia versus normothermia in patients with moderate initial illness severity following resuscitation from out-of-hospital cardiac arrest: protocol for a multicentre randomised controlled trial (R-CAST OHCA).
        Hiromichi Naito; Mitsuaki Nishikimi; Yohei Okada; Hiroki Maeyama; Takeyuki Kiguchi; Takashi Yorifuji; Kazuki Nishida; Shigeyuki Matsui; Yasuhiro Kuroda; Kei Nishiyama; Taku Iwami; Atsunori Nakao
        BMJ open, 22 Aug. 2025
      • Aging affects regrowth of stealthperitoneal dissemination of advanced ovarian cancer: a multicenter retrospective cohort study.
        Hiroki Fujimoto; Masato Yoshihara; Carmela Ricciardelli; Sho Tano; Shohei Iyoshi; Emiri Miyamoto; Kazumasa Mogi; Maia Hayashi; Sae Hayakawa; Satoshi Nomura; Kazuhisa Kitami; Kaname Uno; Nobuhisa Yoshikawa; Ryo Emoto; Shigeyuki Matsui; Hiroaki Kajiyama
        Scientific reports, 09 Oct. 2024
      • Histology-specific long-term oncologic outcomes in patients with epithelial ovarian cancer who underwent complete tumor resection: The implication of occult seeds after initial surgery.
        Kazumasa Mogi; Masato Yoshihara; Ryo Emoto; Emiri Miyamoto; Hiroki Fujimoto; Kaname Uno; Sho Tano; Shohei Iyoshi; Kazuhisa Kitami; Nobuhisa Yoshikawa; Shigeyuki Matsui; Hiroaki Kajiyama
        PloS one, 2024
      • Development and Validation of Predictive Risk Scores for Ovarian Clear Cell Carcinoma: A Penalized Regression Model.
        Shohei Iyoshi; Ryo Emoto; Nobuhisa Yoshikawa; Kosuke Yoshida; Masato Yoshihara; Satoshi Tamauchi; Akira Yokoi; Yusuke Shimizu; Yoshiki Ikeda; Kaoru Niimi; Michiyasu Kawai; Shigeyuki Matsui; Hiroaki Kajiyama
        Cancer medicine, Aug. 2025
      • Detailed analysis of the histology-specific impact of ascites volume on the outcome of epithelial ovarian cancer: a multi-institutional retrospective cohort study.
        Shohei Iyoshi; Mariko Kimura; Masato Yoshihara; Atsushi Kunishima; Emiri Miyamoto; Hiroki Fujimoto; Kazuhisa Kitami; Kazumasa Mogi; Kaname Uno; Sho Tano; Nobuhisa Yoshikawa; Ryo Emoto; Shigeyuki Matsui; Hiroaki Kajiyama
        BMC cancer, 29 Nov. 2024
      • Long-term prognostic significance of ascites cytology in ovarian cancer cases in which R0 resection was achieved in the initial surgery: a multi-institutional retrospective cohort study.
        Shohei Iyoshi; Mayuko Sunohara; Masato Yoshihara; Atsushi Kunishima; Emiri Miyamoto; Hiroki Fujimoto; Kazuhisa Kitami; Kazumasa Mogi; Kaname Uno; Kosuke Yoshida; Satoshi Tamauchi; Akira Yokoi; Kaoru Niimi; Nobuhisa Yoshikawa; Ryo Emoto; Shigeyuki Matsui; Hiroaki Kajiyama
        Japanese journal of clinical oncology, 20 Mar. 2025
      • Evaluating treatment effect modifiers using data from randomized two-sequence, two-period crossover clinical trials: application to a diabetes study
        Ryo Emoto; Masataka Igeta; Kota Matsui; Kiyoaki Ishii; Toshinari Takamura; Shigeyuki Matsui
        Journal of the Royal Statistical Society Series C: Applied Statistics, 06 Feb. 2025
      • Effect Size of Targeted Temperature Management in Pediatric Patients with Post-Cardiac Arrest Syndrome According to the Severity.
        Takeshi Namba; Mitsuaki Nishikimi; Ryo Emoto; Kazuya Kikutani; Shinichiro Ohshimo; Shigeyuki Matsui; Nobuaki Shime
        Life (Basel, Switzerland), 30 Dec. 2024
      • Development of a machine learning-based risk model for postoperative complications of lung cancer surgery.
        Yuka Kadomatsu; Ryo Emoto; Yoko Kubo; Keita Nakanishi; Harushi Ueno; Taketo Kato; Shota Nakamura; Tetsuya Mizuno; Shigeyuki Matsui; Toyofumi Fengshi Chen-Yoshikawa
        Surgery today, Dec. 2024
      • Increased national critical care demands were associated with a higher mortality of intubated COVID-19 patients in Japan: a retrospective observational study.
        Kazuya Kikutani; Mitsuaki Nishikimi; Ryo Emoto; Shigeyuki Matsui; Hiroyuki Ohbe; Takayuki Ogura; Satoru Hashimoto; Shigeki Kushimoto; Shinhiro Takeda; Shinichiro Ohshimo; Nobuaki Shime
        Journal of intensive care, 05 Nov. 2024
      • Identifying Subgroups with Differential Responses to Amiodarone among Cardiac Arrest Patients with a Shockable Rhythm at Hospital Arrival using the Machine Learning Approach.
        Ryo Emoto; Mitsuaki Nishikimi; Kazuya Kikutani; Junki Ishii; Shinichiro Ohshimo; Shigeyuki Matsui; Nobuaki Shime
        Reviews in cardiovascular medicine, Jul. 2024
      • 完全腫瘍切除された上皮性卵巣がん患者での組織型毎の予後検討
        茂木 一将; 吉原 雅人; 江本 遼; 宮本 絵美里; 藤本 裕基; 宇野 枢; 伊吉 祥平; 玉内 学志; 清水 裕介; 横井 暁; 池田 芳樹; 芳川 修久; 新美 薫; 松井 茂之; 梶山 広明
        日本癌治療学会学術集会抄録集, Oct. 2023
      • 完全腫瘍切除された上皮性卵巣がん患者での組織型毎の予後検討
        茂木 一将; 吉原 雅人; 江本 遼; 宮本 絵美里; 藤本 裕基; 宇野 枢; 伊吉 祥平; 玉内 学志; 清水 裕介; 横井 暁; 池田 芳樹; 芳川 修久; 新美 薫; 松井 茂之; 梶山 広明
        日本癌治療学会学術集会抄録集, Oct. 2023
      • Prognostic impact of highly solid component in early-stage solid lung adenocarcinoma
        Taketo Kato; Shingo Iwano; Yuki Hanamatsu; Masato Nakaguro; Ryo Emoto; Shoji Okado; Keiyu Sato; Osamu Noritake; Keita Nakanishi; Yuka Kadomatsu; Harushi Ueno; Naoki Ozeki; Shota Nakamura; Koichi Fukumoto; Tamotsu Takeuchi; Kennosuke Karube; Shigeyuki Matsui; Toyofumi Fengshi Chen-Yoshikawa
        Quantitative Imaging in Medicine and Surgery, 01 Sep. 2023
      • Factors associated with adverse drug reactions or death in very elderly hospitalized patients with pulmonary tuberculosis.
        Mitsuaki Yagi; Yuichiro Shindo; Yoshikazu Mutoh; Masahiro Sano; Toshihiro Sakakibara; Hironori Kobayashi; Akinobu Matsuura; Ryo Emoto; Shigeyuki Matsui; Taku Nakagawa; Kenji Ogawa
        Scientific reports, 26 Apr. 2023
      • Efficacy of Endoscopic Ultrasound-guided Celiac Plexus Neurolysis for Abdominal Pain in Patients With Unresectable Pancreatic Cancer: Network Meta-analysis of Randomized Controlled Trials.
        Okita M; Otani K; Matsui S
        Journal of clinical gastroenterology, 11 Oct. 2022
      • Who are the long-term survivors of recurrent ovarian carcinoma?: a retrospective analysis of a multicenter study.
        Masato Yoshihara; Kazumasa Mogi; Kazuhisa Kitami; Kaname Uno; Shohei Iyoshi; Sho Tano; Hiroki Fujimoto; Emiri Miyamoto; Nobuhisa Yoshikawa; Ryo Emoto; Shigeyuki Matsui; Hiroaki Kajiyama
        International journal of clinical oncology, Oct. 2022
      • Blinded sample size re-estimation for comparing over-dispersed count data incorporating follow-up lengths
        Masataka Igeta; Shigeyuki Matsui
        STATISTICS IN MEDICINE, 23 Sep. 2022
      • Extended-spectrum antibiotics for community-acquired pneumonia with a low risk for drug-resistant pathogens.
        Hironori Kobayashi; Yuichiro Shindo; Daisuke Kobayashi; Toshihiro Sakakibara; Yasushi Murakami; Mitsuaki Yagi; Akinobu Matsuura; Kenta Sato; Kota Matsui; Ryo Emoto; Tetsuya Yagi; Hideo Saka; Shigeyuki Matsui; Yoshinori Hasegawa
        International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 16 Sep. 2022
      • Bias correction based on weighted likelihood for conditional estimation of subgroup effects in randomized clinical trials
        Toyoizumi Kiichiro; Matsui Shigeyuki
        STATISTICS IN MEDICINE, 02 Sep. 2022
      • 糖尿病、肥満、がんとの関係を臨床・疫学・メカニズムから紐解く 卵巣癌腹膜播種の形成における肥満の影響と脱分化脂肪細胞の役割(Impact of obesity and the role of dedifferentiated adipocytes upon peritoneal metastasis of ovarian cancer)
        伊吉 祥平; 吉原 雅人; 中村 香江; 角 朝美; 杉山 麻衣; 小屋 美博; 宮本 絵美里; 藤本 裕基; 茂木 一将; 宇野 枢; 北見 和久; 江本 遼; 松井 茂之; 那波 明宏; 梶山 広明
        日本癌学会総会記事, Sep. 2022
      • 院外心停止例での体温管理療法に関する無作為化比較試験
        内藤 宏道; 錦見 満暁; 岡田 遥平; 前山 博輝; 木口 雄之; 西田 一貴; 松井 茂之; 黒田 泰弘; 西山 慶; 石見 拓; 中尾 篤典
        日本脳低温療法・体温管理学会誌, Sep. 2022
      • 院外心停止例での体温管理療法に関する無作為化比較試験
        内藤 宏道; 錦見 満暁; 岡田 遥平; 前山 博輝; 木口 雄之; 西田 一貴; 松井 茂之; 黒田 泰弘; 西山 慶; 石見 拓; 中尾 篤典
        日本脳低温療法・体温管理学会誌, Sep. 2022
      • Systematic review and meta-analysis of celiac plexus neurolysis for abdominal pain associated with unresectable pancreatic cancer
        Okita Muneyori; Otani Kazuki; Gibo Noriaki; Matsui Shigeyuki
        PAIN PRACTICE, Sep. 2022
      • Effects of lymphocyte and neutrophil counts and their time courses on mortality in patients with postoperative pneumonia
        Yasushi Murakami; Yuichiro Shindo; Masahiro Sano; Junya Okumura; Hironori Kobayashi; Toshihiro Sakakibara; Mitsutaka Iguchi; Kunihiko Takahashi; Tetsuya Yagi; Shigeyuki Matsui; Yoshinori Hasegawa
        Scientific Reports, 26 Aug. 2022
      • The finger-to-nose test improved diagnosis of cerebrovascular events in patients presenting with isolated dizziness in the emergency department.
        Kazuki Nishida; Takuya Usami; Nana Matsumoto; Mitsuaki Nishikimi; Kunihiko Takahashi; Shigeyuki Matsui
        Nagoya journal of medical science, Aug. 2022
      • Obesity contributes to the stealth peritoneal dissemination of ovarian cancer: a multi-institutional retrospective cohort study
        Iyoshi Shohei; Sumi Asami; Yoshihara Masato; Kitami Kazuhisa; Mogi Kazumasa; Uno Kaname; Fujimoto Hiroki; Miyamoto Emiri; Tano Sho; Yoshikawa Nobuhisa; Emoto Ryo; Matsui Shigeyuki; Kajiyama Hiroaki
        OBESITY, Aug. 2022
      • Effect of omega-3 fatty acids on cardiovascular events in high-risk patients with hypertriglyceridemia in Japan: a 3-year post-marketing surveillance study (OCEAN3 survey).
        Tamio Teramoto; Hisao Ogawa; Hirotsugu Ueshima; Yasushi Okada; Kazuo Haze; Shigeyuki Matsui; Keita Fujikawa; Takamasa Hashimoto; Sho Sakui; Kunihiko Nishimura; Mika Kajita; Atsushi Horimoto; Jovelle Fernandez
        Expert opinion on drug safety, 10 Jul. 2022
      • Machine learning prediction models for postpartum depression: A multicenter study in Japan.
        Seiko Matsuo; Takafumi Ushida; Ryo Emoto; Yoshinori Moriyama; Yukako Iitani; Noriyuki Nakamura; Kenji Imai; Tomoko Nakano-Kobayashi; Shigeru Yoshida; Mamoru Yamashita; Shigeyuki Matsui; Hiroaki Kajiyama; Tomomi Kotani
        The journal of obstetrics and gynaecology research, Jul. 2022
      • Prediction of Prehospital Change of the Cardiac Rhythm From Nonshockable to Shockable in Out-of-Hospital Patients With Cardiac Arrest: A Post Hoc Analysis of a Nationwide, Multicenter, Prospective Registry.
        Ryo Emoto; Mitsuaki Nishikimi; Muhammad Shoaib; Kei Hayashida; Kazuki Nishida; Kazuya Kikutani; Shinichiro Ohshimo; Shigeyuki Matsui; Nobuaki Shime; Taku Iwami
        Journal of the American Heart Association, 21 Jun. 2022
      • Epicardial adipose tissue volume is associated with abdominal aortic aneurysm expansion.
        Kawai Y; Banno H; Sato T; Ikeda S; Tsuruoka T; Sugimoto M; Niimi K; Kodama A; Matsui K; Matsui S; Komori K
        Journal of vascular surgery, 01 Jun. 2022
      • Dynamic Risk Prediction via a Joint Frailty-Copula Model and IPD Meta-Analysis: Building Web Applications
        Emura Takeshi; Michimae Hirofumi; Matsui Shigeyuki
        ENTROPY, May 2022
      • Broad-Spectrum Antibiotics and Mortality in Community-Acquired Pneumonia Patients with Low-Risk for Drug-Resistant Pathogens
        Kobayasi H; Shindo Y; Kobayashi D; Sakakibara T; Murakami Y; Yagi M; Matsuura A; Sato K; Goto Y; Matsui S; Yagi T; Saka H; Hasegawa Y
        AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 01 May 2022
      • Risk factors for antibiotic resistance in hospital-acquired and ventilator-associated pneumonia
        Masahiro Sano; Yuichiro Shindo; Kunihiko Takahashi; Junya Okumura; Toshihiro Sakakibara; Yasushi Murakami; Mitsutaka Iguchi; Tetsuya Yagi; Shigeyuki Matsui; Yoshinori Hasegawa
        Journal of Infection and Chemotherapy, Feb. 2022, Peer-reviewed
      • A prediction rule for severe adverse events in all inpatients with community-acquired pneumonia: a multicenter observational study
        Toshihiro Sakakibara; Yuichiro Shindo; Daisuke Kobayashi; Masahiro Sano; Junya Okumura; Yasushi Murakami; Kunihiko Takahashi; Shigeyuki Matsui; Tetsuya Yagi; Hideo Saka; Yoshinori Hasegawa
        BMC Pulmonary Medicine, Jan. 2022, Peer-reviewed
      • 初期粘液性卵巣癌における系統的リンパ節郭清の意義 プロペンシティスコア解析
        茂木 一将; 吉原 雅人; 玉内 学志; 伊吉 祥平; 横井 暁; 河井 通泰; 長坂 徹郎; 高橋 邦彦; 松井 茂之; 梶山 広明
        日本癌治療学会学術集会抄録集, Oct. 2021
      • Postoperative stroke and neurological outcomes in the early phase after revascularization surgeries for moyamoya disease: an age-stratified comparative analysis.
        Yoshio Araki; Kinya Yokoyama; Kenji Uda; Fumiaki Kanamori; Michihiro Kurimoto; Yoshiki Shiba; Takashi Mamiya; Masahiro Nishihori; Takashi Izumi; Masaki Sumitomo; Sho Okamoto; Kota Matsui; Ryo Emoto; Toshihiko Wakabayashi; Shigeyuki Matsui; Atsushi Natsume
        Neurosurgical review, Oct. 2021
      • Hypofibrinogenemia can be estimated by the predictive formula in aortic surgery.
        Toshihiko Nishi; Masato Mutsuga; Toshiaki Akita; Yuji Narita; Kazuro Fujimoto; Yoshiyuki Tokuda; Kazuki Nishida; Shigeyuki Matsui; Kimitoshi Nishiwaki; Akihiko Usui
        General thoracic and cardiovascular surgery, Oct. 2021
      • The rCAST score is useful for estimating the neurological prognosis in pediatric patients with post-cardiac arrest syndrome before ICU admission: External validation study using a nationwide prospective registry.
        Yuma Yasuda; Mitsuaki Nishikimi; Kota Matsui; Atsushi Numaguchi; Kazuki Nishida; Ryo Emoto; Shigeyuki Matsui; Naoyuki Matsuda
        Resuscitation, 30 Sep. 2021
      • Clinical impact of visually assessed right ventricular dysfunction in patients with septic shock.
        Hiroaki Hiraiwa; Daisuke Kasugai; Masayuki Ozaki; Yukari Goto; Naruhiro Jingushi; Michiko Higashi; Kazuki Nishida; Toru Kondo; Kenji Furusawa; Ryota Morimoto; Takahiro Okumura; Naoyuki Matsuda; Shigeyuki Matsui; Toyoaki Murohara
        Scientific reports, 22 Sep. 2021
      • Outcome Related to Level of Targeted Temperature Management in Postcardiac Arrest Syndrome of Low, Moderate, and High Severities: A Nationwide Multicenter Prospective Registry.
        Mitsuaki Nishikimi; Takayuki Ogura; Kazuki Nishida; Kei Hayashida; Ryo Emoto; Shigeyuki Matsui; Naoyuki Matsuda; Taku Iwami
        Critical care medicine, Aug. 2021
      • A large-scale multi-institutional study evaluating prognostic aspects of positive ascites cytology and effects of therapeutic interventions in epithelial ovarian cancer.
        Masato Yoshihara; Ryo Emoto; Kazuhisa Kitami; Shohei Iyoshi; Kaname Uno; Kazumasa Mogi; Sho Tano; Nobuhisa Yoshikawa; Shigeyuki Matsui; Hiroaki Kajiyama
        Scientific reports, 26 Jul. 2021
      • Relative platelet reductions provide better pathophysiologic signatures of coagulopathies in sepsis
        Daisuke Kasugai; Masayuki Ozaki; Kazuki Nishida; Yukari Goto; Kunihiko Takahashi; Shigeyuki Matsui; Naoyuki Matsuda
        Scientific Reports, 07 Jul. 2021
      • The interplay between bystander cardiopulmonary resuscitation and ambient temperature on neurological outcome after cardiac arrest: A nationwide observational cohort study.
        Kei Hayashida; Ryosuke Takegawa; Mitsuaki Nishikimi; Tomoaki Aoki; Ryo Emoto; Koichiro Shinozaki; Santiago J Miyara; Daniel M Rolston; Timmy Li; Muhammad Shoaib; Tatsuma Fukuda; Ernesto P Molmenti; Masaru Suzuki; Junichi Sasaki; Shigeyuki Matsui; Lance B Becker
        Resuscitation, Jul. 2021
      • Semi-parametric empirical Bayes factor for genome-wide association studies
        Junji Morisawa; Takahiro Otani; Jo Nishino; Ryo Emoto; Kunihiko Takahashi; Shigeyuki Matsui
        European Journal of Human Genetics, May 2021
      • Statistical Models in Clinical Studies
        Matsui Shigeyuki; Le-Rademacher Jennifer; Mandrekar Sumithra J
        JOURNAL OF THORACIC ONCOLOGY, May 2021
      • Failure of non-invasive respiratory support after 6 hours from initiation is associated with ICU mortality.
        Mitsuaki Nishikimi; Kazuki Nishida; Yuichiro Shindo; Muhammad Shoaib; Daisuke Kasugai; Yuma Yasuda; Michiko Higashi; Atsushi Numaguchi; Takanori Yamamoto; Shigeyuki Matsui; Naoyuki Matsuda
        PloS one, 30 Apr. 2021
      • Blinded Sample Size Re-Estimation in Comparative Clinical Trials With Overdispersed Count Data: Incorporation of Misspecification of the Variance Function
        Masataka Igeta; Shigeyuki Matsui
        STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 03 Apr. 2021
      • Prognostic value of desmoplastic reaction characterisation in stage II colon cancer: prospective validation in a Phase 3 study (SACURA Trial).
        Hideki Ueno; Megumi Ishiguro; Eiji Nakatani; Toshiaki Ishikawa; Hiroyuki Uetake; Kenta Murotani; Shigeyuki Matsui; Satoshi Teramukai; Tamotsu Sugai; Yoichi Ajioka; Hirotoshi Maruo; Masahito Kotaka; Masaki Tsujie; Yoshinori Munemoto; Takashi Yamaguchi; Hisashi Kuroda; Mutsumi Fukunaga; Naohiro Tomita; Kenichi Sugihara
        British journal of cancer, 16 Mar. 2021
      • Does complete-staging lymphadenectomy improve survival outcomes in stage I endometrioid epithelial ovarian carcinoma? A multi-institutional retrospective study with propensity score-weighted analysis.
        Masato Yoshihara; Satoshi Tamauchi; Shohei Iyoshi; Kazuhisa Kitami; Kaname Uno; Sho Tano; Shigeyuki Matsui; Hiroaki Kajiyama
        Japanese journal of clinical oncology, Mar. 2021
      • Effect-Size Estimation Using Semiparametric Hierarchical Mixture Models in Disease-Association Studies with Neuroimaging Data
        Ryo Emoto; Atsushi Kawaguchi; Kunihiko Takahashi; Shigeyuki Matsui
        Computational and Mathematical Methods in Medicine, 09 Dec. 2020
      • Relationship Between Bone Mineral Density and Risk of Vertebral Fractures with Denosumab Treatment in Japanese Postmenopausal Women and Men with Osteoporosis
        Okubo Naoki; Matsui Shigeyuki; Matsumoto Toshio; Sugimoto Toshitsugu; Hosoi Takayuki; Osakabe Taisuke; Watanabe Ko; Takami Hideo; Shiraki Masataka; Nakamura Toshitaka
        CALCIFIED TISSUE INTERNATIONAL, Dec. 2020
      • Optimal Criteria for G3 (Poorly Differentiated) Stage II Colon Cancer: Prospective Validation in a Randomized Controlled Study (SACURA Trial).
        Hideki Ueno; Megumi Ishiguro; Eiji Nakatani; Toshiaki Ishikawa; Hiroyuki Uetake; Shigeyuki Matsui; Satoshi Teramukai; Kenta Murotani; Yoichi Ajioka; Hideyuki Shimazaki; Atsuyuki Maeda; Kunio Takuma; Takefumi Yoshida; Takeshi Kambara; Keiji Matsuda; Akinori Takagane; Naohiro Tomita; Kenichi Sugihara
        The American journal of surgical pathology, Dec. 2020
      • The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies.
        Shogo Kumagai; Yosuke Togashi; Takahiro Kamada; Eri Sugiyama; Hitomi Nishinakamura; Yoshiko Takeuchi; Kochin Vitaly; Kota Itahashi; Yuka Maeda; Shigeyuki Matsui; Takuma Shibahara; Yasuho Yamashita; Takuma Irie; Ayaka Tsuge; Shota Fukuoka; Akihito Kawazoe; Hibiki Udagawa; Keisuke Kirita; Keiju Aokage; Genichiro Ishii; Takeshi Kuwata; Kenta Nakama; Masahito Kawazu; Toshihide Ueno; Naoya Yamazaki; Koichi Goto; Masahiro Tsuboi; Hiroyuki Mano; Toshihiko Doi; Kohei Shitara; Hiroyoshi Nishikawa
        Nature immunology, Nov. 2020
      • Desmoid with biweekly methotrexate and vinblastine shows similar effects to weekly administration: A phase II clinical trial
        Nishida Yoshihiro; Hamada Shunsuke; Urakawa Hiroshi; Ikuta Kunihiro; Sakai Tomohisa; Koike Hiroshi; Ito Kan; Emoto Ryo; Ando Yuichi; Matsui Shigeyuki
        CANCER SCIENCE, Nov. 2020
      • Impact of uterus‐preserving surgery on Stage I primary mucinous epithelial ovarian carcinoma: A multi‐institutional study with propensity score‐weighted analysis
        Masato Yoshihara; Hiroaki Kajiyama; Satoshi Tamauchi; Shohei Iyoshi; Akira Yokoi; Shiro Suzuki; Michiyasu Kawai; Tetsuro Nagasaka; Kunihiko Takahashi; Shigeyuki Matsui; Fumitaka Kikkawa
        International Journal of Gynecology & Obstetrics, Aug. 2020
      • High-flow nasal cannula therapy for acute respiratory failure in patients with interstitial pneumonia: a retrospective observational study.
        Norihito Omote; Naoyuki Matsuda; Naozumi Hashimoto; Kazuki Nishida; Koji Sakamoto; Akira Ando; Yoshio Nakahara; Mitsuaki Nishikimi; Michiko Higashi; Shigeyuki Matsui; Yoshinori Hasegawa
        Nagoya journal of medical science, May 2020
      • A single paravertebral injection via a needle vs. a catheter for the spreading to multiple intercostal levels: a randomized controlled trial
        Fujii Tasuku; Shibata Yasuyuki; Ban Yasutaka; Shitaokoshi Akira; Takahashi Kunihiko; Matsui Shigeyuki; Nishiwaki Kimitoshi
        JOURNAL OF ANESTHESIA, Feb. 2020
      • More Powerful Selective Kernel Tests for Feature Selection.
        Jen Ning Lim; Makoto Yamada; Wittawat Jitkrittum; Yoshikazu Terada; Shigeyuki Matsui; Hidetoshi Shimodaira
        The 23rd International Conference on Artificial Intelligence and Statistics(AISTATS), 2020
      • Prognostic impact of pelvic and para-aortic lymphadenectomy on clinically-apparent stage I primary mucinous epithelial ovarian carcinoma: a multi-institutional study with propensity score-weighted analysis
        Yoshihara M; Kajiyama H; Tamauchi S; Iyoshi S; Yokoi A; Suzuki S; Kawai M; Nagasaka T; Takahashi K; Matsui S; Kikkawa F
        Japanese Journal of Clinical Oncology, 2020, Peer-reviewed
      • Diagnosis of central diabetes insipidus using a vasopressin radioimmunoassay during hypertonic saline infusion
        Takagi H; Hagiwara D; Handa T; Sugiyama M; Onoue T; Tsunekawa T; Ito Y; Iwama S; Goto M; Suga H; Banno R; Takahashi K; Matsui S; Arima H
        Endocrine Journal, 2020, Peer-reviewed
      • Relationship Between Serum Norepinephrine Levels at ICU Admission and the Risk of ICU-Acquired Delirium: Secondary Analysis of the Melatonin Evaluation of Lowered Inflammation of ICU Trial
        Yasuda Y; Nishikimi M; Nishida K; Takahashi K; Numaguchi A; Higashi M; Matsui S; Matsuda N
        Critical Care Explorations, 2020, Peer-reviewed
      • Prognostic factors and effects of fertility-sparing surgery in women of reproductive age with ovarian clear-cell carcinoma: a propensity score analysis.
        Masato Yoshihara; Hiroaki Kajiyama; Satoshi Tamauchi; Shiro Suzuki; Kunihiko Takahashi; Shigeyuki Matsui; Fumitaka Kikkawa
        Journal of gynecologic oncology, Nov. 2019
      • Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage II Colon Cancer: Results From the SACURA Trial.
        Hideki Ueno; Megumi Ishiguro; Eiji Nakatani; Toshiaki Ishikawa; Hiroyuki Uetake; Chu Matsuda; Yoshihiko Nakamoto; Masanori Kotake; Kiyotaka Kurachi; Tomohisa Egawa; Keigo Yasumasa; Kohei Murata; Osamu Ikawa; Seiichi Shinji; Kenta Murotani; Shigeyuki Matsui; Satoshi Teramukai; Naohiro Tomita; Kenichi Sugihara
        Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 01 Aug. 2019, Peer-reviewed
      • Statistical testing strategies for assessing treatment efficacy and marker accuracy in phase III trials.
        Takahiro Nonaka; Masataka Igeta; Shigeyuki Matsui
        Pharmaceutical statistics, Jul. 2019
      • Novel multi-gene classifier for prediction of relapse-free survival after FU-based adjuvant chemotherapy for stage III colon cancer: A biomarker study of the ACTS-C trial, a randomized controlled study
        Ishikawa Toshiaki; Murotani Kenta; Ishiguro Megumi; Nakatani Eiji; Uetake Hiroyuki; Matsui Shigeyuki; Sugihara Kenichi
        CANCER RESEARCH, Jul. 2019
      • External validation of a risk classification at the emergency department of post-cardiac arrest syndrome patients undergoing targeted temperature management.
        Nishikimi M; Ogura T; Nishida K; Takahashi K; Nakamura M; Matsui S; Matsuda N; Iwami T
        Resuscitation, 30 May 2019
      • Timing of administration of epinephrine predicts the responsiveness to epinephrine in norepinephrine-refractory septic shock: a retrospective study
        Kasugai Daisuke; Nishikimi Mitsuaki; Nishida Kazuki; Higashi Michiko; Yamamoto Takanori; Numaguchi Atsushi; Takahashi Kunihiko; Matsui Shigeyuki; Matsuda Naoyuki
        JOURNAL OF INTENSIVE CARE, 05 Apr. 2019
      • Development of novel diagnostic system for pancreatic cancer, including early stages, measuring mRNA of whole blood cells
        Yoshio Sakai; Masao Honda; Shigeyuki Matsui; Osamu Komori; Toshinori Murayama; Tadami Fujiwara; Masaaki Mizuno; Yasuhito Imai; Kenichi Yoshimura; Alessandro Nasti; Takashi Wada; Noriho Iida; Masaaki Kitahara; Rika Horii; Tamai Toshikatsu; Masashi Nishikawa; Hirofumi Okafuji; Eishiro Mizukoshi; Tatsuya Yamashita; Taro Yamashita; Kuniaki Arai; Kazuya Kitamura; Kazunori Kawaguchi; Hajime Takatori; Tetsuro Shimakami; Takeshi Terashima; Tomoyuki Hayashi; Kouki Nio; Shuichi Kaneko
        Cancer Science, Apr. 2019
      • [Na+] Increases in body fluids sensed by central Nax induce sympathetically mediated blood pressure elevations via H+-dependent activation of ASIC1a
        Nomura K; Hiyama TY; Sakuta H; Matsuda T; Lin CH; Kobayashi K; Kobayashi K; Kuwaki T; Takahashi K; Matsui S; Noda M
        Neuron, 02 Jan. 2019, Peer-reviewed
      • More Powerful Selective Kernel Tests for Feature Selection.
        Jen Ning Lim; Makoto Yamada; Wittawat Jitkrittum; Yoshikazu Terada; Shigeyuki Matsui; Hidetoshi Shimodaira
        CoRR, 2019, Peer-reviewed
      • Rule-Based Designs Considering Toxicity Alone
        Daimon Takashi; Hirakawa Akihiro; Matsui Shigeyuki
        DOSE-FINDING DESIGNS FOR EARLY-PHASE CANCER CLINICAL TRIALS: A BRIEF GUIDEBOOK TO THEORY AND PRACTICE, 2019
      • Model-Based Designs Considering Toxicity Alone
        Daimon Takashi; Hirakawa Akihiro; Matsui Shigeyuki
        DOSE-FINDING DESIGNS FOR EARLY-PHASE CANCER CLINICAL TRIALS: A BRIEF GUIDEBOOK TO THEORY AND PRACTICE, 2019
      • Model-Assisted Designs Considering Toxicity Alone
        Daimon Takashi; Hirakawa Akihiro; Matsui Shigeyuki
        DOSE-FINDING DESIGNS FOR EARLY-PHASE CANCER CLINICAL TRIALS: A BRIEF GUIDEBOOK TO THEORY AND PRACTICE, 2019
      • Early-Phase Cancer Clinical Trials
        Daimon Takashi; Hirakawa Akihiro; Matsui Shigeyuki
        DOSE-FINDING DESIGNS FOR EARLY-PHASE CANCER CLINICAL TRIALS: A BRIEF GUIDEBOOK TO THEORY AND PRACTICE, 2019
      • Dose-Finding Designs for Early-Phase Cancer Clinical Trials A Brief Guidebook to Theory and Practice Preface
        Daimon Takashi; Hirakawa Akihiro; Matsui Shigeyuki
        DOSE-FINDING DESIGNS FOR EARLY-PHASE CANCER CLINICAL TRIALS: A BRIEF GUIDEBOOK TO THEORY AND PRACTICE, 2019
      • Designs for Early-Phase Immunotherapeutic Agent Trials
        Daimon Takashi; Hirakawa Akihiro; Matsui Shigeyuki
        DOSE-FINDING DESIGNS FOR EARLY-PHASE CANCER CLINICAL TRIALS: A BRIEF GUIDEBOOK TO THEORY AND PRACTICE, 2019
      • Designs Considering Toxicity and Efficacy
        Daimon Takashi; Hirakawa Akihiro; Matsui Shigeyuki
        DOSE-FINDING DESIGNS FOR EARLY-PHASE CANCER CLINICAL TRIALS: A BRIEF GUIDEBOOK TO THEORY AND PRACTICE, 2019
      • Application of the Multi-Dimensional Hierarchical Mixture Model to Cross-Disorder Genome-Wide Association Studies
        Otani Takahiro; Nishino Jo; Emoto Ryo; Matsui Shigeyuki
        16TH INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY-NEW GENERATIONS (ITNG 2019), 2019
      • A New Scoring System for Predicting Adverse Events in Hospitalized Patients with Community-Onset Pneumonia
        Sakakibara T; Shindo Y; Takahashi K; Kobayashi D; Okumura J; Sano M; Murakami Y; Thabet N; Kobayashi H; Yagi T; Matsui S; Saka H; Hasegawa Y
        AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019
      • A Model-Based Framework for Voxel and Region Level Inferences in Neuroimaging Disease-Association Studies
        Emoto Ryo; Kawaguchi Atsushi; Otani Takahiro; Matsui Shigeyuki
        16TH INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY-NEW GENERATIONS (ITNG 2019), 2019
      • Exploring predictive biomarkers from clinical genome-wide association studies via multidimensional hierarchical mixture models.
        Otani T; Noma H; Sugasawa S; Kuchiba A; Goto A; Yamaji T; Kochi Y; Iwasaki M; Matsui S; Tsunoda T
        European Journal of Human Genetics, Jan. 2019, Peer-reviewed
      • compound.Cox: univariate feature selection and compound covariate for predicting survival.
        Emura T; Matsui S; Chen HY
        Computer Methods and Programs in Biomedicine, Jan. 2019, Peer-reviewed
      • Clinical frailty scale score before ICU admission is associated with mobility disability in septic patients receiving early rehebilitation
        Nakajima H; Nishikimi M; Shimizu M; Hayashi K; Inoue T; Nishida K; Takahashi K; Matsui S; Nishida Y; Matsuda N
        Critical Care Explorations, 2019, Peer-reviewed
      • A randomised controlled trial of pectoralis nerves-2 (PECS 2) block versus serratus plane block for chronic pain after mastectomy
        Fujii T; Shibata Y; Akane A; Aoki W; Sekiguchi A; Takahashi K; Matsui S; Nishiwaki K
        Anaesthesia, 2019, Peer-reviewed
      • Steeper macular curvature in eyes with non-highly myopic retinitis pigmentosa
        Komori S; Ueno S; Ito Y; Sayo A; Meinert M; Kominami T; Inooka D; Kitagawa M; Nishida K; Takahashi K; Matsui S; Terasaki H
        Investigative Ophthalmology & Visual Science, 2019, Peer-reviewed
      • Maximum norepinephrine dosage within 24 hours as an indicator of refractory septic shock: a retrospective study
        Kasugai D; Hirakawa A; Ozaki M; Nishida K; Ikeda T; Takahashi K; Matsui S; Uenishi N
        Journal of Intensive Care Medicine, 2019, Peer-reviewed
      • Two-stage analysis for selecting fixed numbers of features in omics association studies
        Kawabata T; Emoto R; Nishino J; Takahashi K; Matsui S
        Statistics in Medicine, 2019, Peer-reviewed
      • The authors reply
        Mitsuaki Nishikimi; Atsushi Numaguchi; Kunihiko Takahashi; Shigeyuki Matsui; Naoyuki Matsuda
        Critical Care Medicine, Dec. 2018
      • Comprehensive Search for Prognostic Biomarkers using PCAWG Data
        Mamoru Kato; Momoko Nagai; Takanori Hasegawa; Seiya Imoto; Shigeyuki Matsui; Tatsuhiko Tsunoda; Tatsuhiro Shibata
        CANCER SCIENCE, Dec. 2018
      • Sleep, the Missing Link? Reply
        Nishikimi Mitsuaki; Numaguchi Atsushi; Takahashi Kunihiko; Matsui Shigeyuki; Matsuda Naoyuki
        CRITICAL CARE MEDICINE, Dec. 2018
      • Two-stage approach based on zone and dose findings for two-agent combination Phase I/II trials
        Shimamura Fumiya; Hamada Chikuma; Matsui Shigeyuki; Hirakawa Akihiro
        JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 02 Nov. 2018
      • Prognostic impact of MSI and 18qLOH in stage II colon cancer: A prospective biomarker study in the SACURA trial
        Ishikawa T; Ishiguro M; Nakatani E; Ueno H; Uetake H; Murotani K; Matsui S; Tomita N; Shimada Y; Takahashi K; Kotake K; Watanabe M; Mochizuki H; Teramukai S; Sugihara K
        ANNALS OF ONCOLOGY, Oct. 2018
      • Early Administration of Ramelteon in the ICU: Effects Deserve Further Study Reply
        Nishikimi Mitsuaki; Numaguchi Atsushi; Takahashi Kunihiko; Matsui Shigeyuki; Matsuda Naoyuki
        CRITICAL CARE MEDICINE, Oct. 2018
      • Personalized dynamic prediction of death according to tumour progression and high-dimensional genetic factors: Meta-analysis with a joint model.
        Emura T; Nakatochi M; Matsui S; Michimae H; Rondeau V
        Statistical Methods in Medical Research, Sep. 2018, Peer-reviewed
      • Global overexpression of divalent metal transporter 1 delays crocidolite-induced mesothelial carcinogenesis in male mice.
        Satomi Funahashi; Yasumasa Okazaki; Takahiro Nishiyama; Hidekazu Ohyoshi; Hiroyuki Yasui; Kazuki Nishida; Shigeyuki Matsui; Shinya Toyokuni
        Free radical research, Sep. 2018, Peer-reviewed
      • Preoperative six-minute walk distance is associated with postoperative cognitive dysfunction.
        Hayashi K; Oshima H; Shimizu M; Kobayashi K; Matsui S; Nishida Y; Usui A
        Annals of Thoracic Surgery, Aug. 2018, Peer-reviewed
      • Re-assessment of multiple testing strategies for more efficient genome-wide association studies.
        Otani T; Noma H; Nishino J; Matsui S
        European Journal of Human Genetics, Jul. 2018, Peer-reviewed
      • Effect of Administration of Ramelteon, a Melatonin Receptor Agonist, on the Duration of Stay in the ICU: A Single-Center Randomized Placebo-Controlled Trial
        Nishikimi Mitsuaki; Numaguchi Atsushi; Takahashi Kunihiko; Miyagawa Yasuhiro; Matsui Kota; Higashi Michiko; Makishi Go; Matsui Shigeyuki; Matsuda Naoyuki
        CRITICAL CARE MEDICINE, Jul. 2018
      • Differential effect of mild therapeutic hypothermia depending on the findings of hypoxic encephalopathy on early CT images in patients with post-cardiac arrest syndrome
        Nishikimi Mitsuaki; Ogura Takayuki; Nishida Kazuki; Takahashi Kunihiko; Fukaya Kenji; Liu Keibun; Nakamura Mitsunobu; Matsui Shigeyuki; Matsuda Naoyuki
        RESUSCITATION, Jul. 2018
      • Sample Size for Successful Genome-Wide Association Study of Major Depressive Disorder.
        Jo Nishino; Hidenori Ochi; Yuta Kochi; Tatsuhiko Tsunoda; Shigeyuki Matsui
        Frontiers in genetics, 28 Jun. 2018
      • The current state of therapeutic development for rare cancers in Japan, and proposals for improvement.
        Kawai A; Goto T; Shibata T; Tani K; Mizutani S; Nishikawa A; Shibata T; Matsumoto S; Nagata K; Narukawa M; Matsui S; Ando M; Toguchida J; Monden M; Heike T; Kimura S; Ueda R
        Cancer Science, May 2018, Peer-reviewed
      • Accuracy of the first interpretation of early brain CT images for predicting the prognosis of post-cardiac arrest syndrome patients at the emergency department
        Nishikimi Mitsuaki; Ogura Takayuki; Matsui Kota; Takahashi Kunihiko; Fukaya Kenji; Liu Keibun; Morita Hideo; Nakamura Mitsunobu; Matsui Shigeyuki; Matsuda Naoyuki
        JOURNAL OF INTENSIVE CARE, 25 Apr. 2018
      • Empirical Bayes estimation of semi-parametric hierarchical mixture models for unbiased characterization of polygenic disease architectures.
        Nishino J; Kochi Y; Shigemizu D; Kato M; Ikari K; Ochi H; Noma H; Matsui K; Morizono T; Boroevich K; Tsunoda T; Matsui S
        Frontiers in Genetics, 24 Apr. 2018, Peer-reviewed
      • Biomarker-Stratified Phase III Clinical Trials: Enhancement with a Subgroup-Focused Sequential Design
        Matsui Shigeyuki; Crowley John
        CLINICAL CANCER RESEARCH, 01 Mar. 2018
      • Multi-subgroup gene screening using semi-parametric hierarchical mixture models and the optimal discovery procedure: application to a randomized clinical trial in multiple myeloma
        Matsui, S; Noma, H; Qu, P; Sakai, Y; Matsui, K; Heuck, C; Crowley, J
        Biometrics, Mar. 2018, Peer-reviewed
      • Modern Dose-Finding Designs for Cancer Phase I Trials: Drug Combinations and Molecularly Targeted Agents Preface
        Hirakawa Akihiro; Sato Hiroyuki; Daimon Takashi; Matsui Shigeyuki
        MODERN DOSE-FINDING DESIGNS FOR CANCER PHASE I TRIALS: DRUG COMBINATIONS AND MOLECULARLY TARGETED AGENTS, 2018
      • Dose Finding in Phase I Cancer Trials
        Hirakawa Akihiro; Sato Hiroyuki; Daimon Takashi; Matsui Shigeyuki
        MODERN DOSE-FINDING DESIGNS FOR CANCER PHASE I TRIALS: DRUG COMBINATIONS AND MOLECULARLY TARGETED AGENTS, 2018
      • Dose Finding for Molecularly Targeted Agents (MTAs)
        Hirakawa Akihiro; Sato Hiroyuki; Daimon Takashi; Matsui Shigeyuki
        MODERN DOSE-FINDING DESIGNS FOR CANCER PHASE I TRIALS: DRUG COMBINATIONS AND MOLECULARLY TARGETED AGENTS, 2018
      • Dose Finding for Joint Assessment of Both Efficacy and Toxicity
        Hirakawa Akihiro; Sato Hiroyuki; Daimon Takashi; Matsui Shigeyuki
        MODERN DOSE-FINDING DESIGNS FOR CANCER PHASE I TRIALS: DRUG COMBINATIONS AND MOLECULARLY TARGETED AGENTS, 2018
      • Dose Finding for a Combination of Two Agents
        Hirakawa Akihiro; Sato Hiroyuki; Daimon Takashi; Matsui Shigeyuki
        MODERN DOSE-FINDING DESIGNS FOR CANCER PHASE I TRIALS: DRUG COMBINATIONS AND MOLECULARLY TARGETED AGENTS, 2018
      • Advanced Topics on Dose-Finding Designs
        Hirakawa Akihiro; Sato Hiroyuki; Daimon Takashi; Matsui Shigeyuki
        MODERN DOSE-FINDING DESIGNS FOR CANCER PHASE I TRIALS: DRUG COMBINATIONS AND MOLECULARLY TARGETED AGENTS, 2018
      • Immune condition of colorectal cancer patients featured by serum chemokines and gene expressions of CD4+ cells in blood.
        Komura T; Yano M; Miyake A; Takabatake H; Miyazawa M; Ogawa N; Seki A; Honda M; Wada T; Matsui S; Kaneko S; Sakai Y
        Canadian Journal of Gastroenterology and Hepatology, 2018, Peer-reviewed
      • Mortality in patients with community-onset pneumonia at low risk of drug-resistant pathogens: Impact of β-lactam plus macrolide combination therapy
        Okumura J; Shindo Y; Takahashi K; Sano M; Sugino Y; Yagi T; Taniguchi H; Saka H; Matsui S; Hasegawa Y
        Respirology, 2018, Peer-reviewed
      • Treatment of patients with sepsis in a closed Intensive Care Unit is associated with improved survival: A nationwide observational study in Japan
        Ogura T; Nakamura Y; Takahashi K; Nishida K; Kobashi D; Matsui S
        Journal of Intensive Care, 2018, Peer-reviewed
      • Power and sample size calculation incorporating misspecifications of the variance function in comparative clinical trials with over-dispersed count data
        Igeta M; Takahashi K; Matsui S
        Biometrics, 2018, Peer-reviewed
      • A dose-response meta-analysis of coffee consumption and colorectal cancer risk in the Japanese population: application of a cubic-spline model
        Horisaki K; Takahashi K; Ito H; Matsui S
        Journal of Epidemiology, 2018, Peer-reviewed
      • High-Flow Nasal Cannula Therapy for Acute Respiratory Failure in Patients with Interstitial Pneumonia: A Retrospective Observational Study
        Omote N; Hashimoto N; Matsuda N; Nishida K; Sakamoto K; Ando A; Nakahara Y; Nishikimi M; Higashi M; Matsui S; Hasegawa Y
        AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018
      • IMPLICATION OF beta-LACTAM PLUS MACROLIDE COMBINATION THERAPY ON MORTALITY IN PATIENTS WITH COMMUNITY-ONSET PNEUMONIA AT LOW RISK FOR DRUG-RESISTANT PATHOGENS
        Okumura Junya; Shindo Yuichiro; Sano Masahiro; Sakakibara Toshihiro; Matsuda Toshiaki; Takahashi Kunihiko; Saka Hideo; Matsui Shigeyuki; Hasegawa Yoshinori
        RESPIROLOGY, Nov. 2017
      • Risk Factors For Severe Adverse Outcomes In Patients With Hospital-Acquired Pneumonia
        Sano M; Shindo Y; Okumura J; Sakakibara T; Matsuda T; Yagi T; Matsui K; Takahashi K; Matsui S; Hasegawa Y
        AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017
      • Diurnal variations in blood flow at optic nerve head and choroid in healthy eyes: diurnal variations in blood flow.
        Iwase T; Yamamoto K; Ra E; Murotani K; Matsui S; Terasaki H
        Medicine (Baltimore)., 2015, Peer-reviewed
      • Idiopathic sudden sensorineural hearing loss in Japan.
        Nakashima T; Sato H; Gyo K; Hato N; Yoshida T; Shimono M; Teranishi M; Sone M; Fukunaga Y; Kobashi G; Takahashi K; Matsui S; Ogawa K
        Acta oto-laryngologica, Nov. 2014, Peer-reviewed
      • Dose-finding methods for two-agent combination phase i trials
        Akihiro Hirakawa; Shigeyuki Matsui
        Developments in Statistical Evaluation of Clinical Trials, 01 Apr. 2014, Peer-reviewed
      • Endoscopic evaluation of low-dose aspirin-induced gastric and duodenal ulcers during prophylaxis with lansoprazole.
        Nobuhiro Sakaki; Kiyoshi Ashida; Yuji Mizokami; Tsutomu Chiba; Shigeyuki Matsui; Tatsuya Kanto; Naomi Uemura; Naoki Hiramatsu; Kentaro Sugano
        Hepato-gastroenterology, Jun. 2013, Peer-reviewed
      • Bayesian Ranking and Selection Methods in Microarray Studies
        Hisashi Noma; Shigeyuki Matsui
        Statistical Diagnostics for Cancer: Analyzing High-Dimensional Data, 08 Apr. 2013
      • PP-816 SNPアレイを用いた転移性前立腺癌の生存期間に関与する癌関連遺伝子の探索(発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会)
        土谷 順彦; 成田 伸太郎; 井上 高光; 鶴田 大; 沼倉 一幸; 堀川 洋平; 畠山 真吾; 大山 力; 荒井 陽一; 小川 修; 斎藤 誠一; 松井 茂之; 羽渕 友則
        日本泌尿器科学会雑誌, 2011
      • Sorafenib efficacy in ovarian clear cell carcinoma revealed by transcriptome profiling
        Noriomi Matsumura; Masaki Mandai; Takako Okamoto; Ken Yamaguchi; Shogo Yamamura; Tomonori Oura; Tsukasa Baba; Junzo Hamanishi; Hyun S. Kang; Shigeyuki Matsui; Seiichi Mori; Susan K. Murphy; Ikuo Konishi
        CANCER SCIENCE, Dec. 2010, Peer-reviewed
      • Statistical Analysis of Microarray Data : How to Avoid Pitfalls
        MATSUI Shigeyuki
        KAGAKU TO SEIBUTSU, 01 Nov. 2008
      • Comments on Points to Consider on Missing Data
        MATSUI Shigeyuki
        Japanese Journal of Biometrics, 30 Sep. 2006
      • Lessons from gefitinib-induced interstitial lung disease in Japan: Problems in approval, pharmacovigilance, and regulatory decision-making procedures
        Tsutomu Nishimura; Harue Tada; Masatsugu Nakagawa; Satoshi Teramukai; Shigeyuki Matsui; Masanori Fukushima
        Pharmacy Practice, 2006
      • Summary
        Matsui Shigeyuki
        Japanese Journal of Biometrics, 2006

      Misc.

      • Prediction of survival in patients with metastatic prostate cancer by single nucleotide polymorphisms of cancer-associated genes.
        Takamitsu Inoue; Norihiko Tsuchiya; Shigeyuki Matsui; Tomomi Kamba; Koji Mitsuzuka; Shingo Hatakeyama; Yohei Horikawa; Chikara Ohyama; Seiichi Saito; Yoichi Arai; Osamu Ogawa; Tomonori Habuchi
        JOURNAL OF CLINICAL ONCOLOGY, Feb. 2012
      • 初期粘液性卵巣癌における系統的リンパ節郭清の意義 プロペンシティスコア解析
        茂木 一将; 吉原 雅人; 玉内 学志; 伊吉 祥平; 横井 暁; 河井 通泰; 長坂 徹郎; 高橋 邦彦; 松井 茂之; 梶山 広明
        日本癌治療学会学術集会抄録集, Oct. 2021
      • Stage II結腸癌における18qCIN(Chromosomal Instability)と予後の検討 SACURA試験バイオマーカー研究
        石川 敏昭; 中谷 英仁; 石黒 めぐみ; 上野 秀樹; 室谷 健太; 松井 茂之; 手良向 聡; 植竹 宏之; 冨田 尚裕; 杉原 健一; SACURA Study Group
        日本大腸肛門病学会雑誌, May 2019
      • Stage II結腸癌における18qCIN(Chromosomal Instability)と予後の検討 SACURA試験バイオマーカー研究
        石川 敏昭; 中谷 英仁; 石黒 めぐみ; 上野 秀樹; 室谷 健太; 松井 茂之; 手良向 聡; 植竹 宏之; 冨田 尚裕; 杉原 健一; SACURA Study Group
        日本大腸肛門病学会雑誌, May 2019
      • Stage II結腸癌における18qCIN(Chromosomal Instability)と予後の検討~SACURA試験バイオマーカー研究
        石川敏昭; 中谷英仁; 石黒めぐみ; 上野秀樹; 室谷健太; 松井茂之; 手良向聡; 植竹宏之; 冨田尚裕; 杉原健一
        日本大腸肛門病学会雑誌(Web), 2019
      • The authors reply
        Mitsuaki Nishikimi; Atsushi Numaguchi; Kunihiko Takahashi; Shigeyuki Matsui; Naoyuki Matsuda
        Critical care medicine, 01 Oct. 2018
      • オミクス研究における検証的解析と探索的解析:多重検定とP値を中心に
        松井 茂之
        計量生物学, 2018, Peer-reviewed
      • Longitudinal study of visual field changes determined by Humphrey Field Analyzer 10-2 in patients with Retinitis Pigmentosa
        Akira Sayo; Shinji Ueno; Taro Kominami; Kazuki Nishida; Daiki Inooka; Ayami Nakanishi; Shunsuke Yasuda; Satoshi Okado; Kunihiko Takahashi; Shigeyuki Matsui; Hiroko Terasaki
        SCIENTIFIC REPORTS, Nov. 2017, Peer-reviewed
      • Frontiers of biostatistical methods and applications in clinical oncology
        Shigeyuki Matsui; John Crowley
        Frontiers of Biostatistical Methods and Applications in Clinical Oncology, 03 Oct. 2017
      • ハイリスクStage II大腸癌の治療戦略 Stage II結腸癌における再発リスクの層別と治療戦略の展望 SACURA trialの結果から
        石黒 めぐみ; 上野 秀樹; 石川 敏昭; 中谷 英仁; 手良向 聡; 松井 茂之; 室谷 健太; 望月 英隆; 固武 健二郎; 高橋 慶一; 渡邊 昌彦; 島田 安博; 冨田 尚裕; 植竹 宏之; 杉原 健一
        日本臨床外科学会雑誌, Oct. 2017
      • 臨床応用を目指した消化器外科領域の基礎研究・橋渡し研究 Stage II結腸癌に対する術後補助化学療法の第III相試験(SACURA trial)におけるMSIと予後の検討
        石川 敏昭; 植竹 宏之; 石黒 めぐみ; 室谷 健太; 上野 秀樹; 松井 茂之; 中谷 英仁; 手良向 聡; 冨田 尚裕; 杉原 健一
        日本消化器外科学会総会, Jul. 2017
      • Stage II結腸癌におけるdesmoplastic reaction分類の臨床的意義 SACURA trialにおける前向き付随研究
        上野 秀樹; 石黒 めぐみ; 石川 敏昭; 中谷 英仁; 室谷 健太; 松井 茂之; 手良向 聡; 植竹 宏之; 冨田 尚裕; 杉原 健一
        日本消化器外科学会総会, Jul. 2017
      • 臨床応用を目指した消化器外科領域の基礎研究・橋渡し研究 Stage II結腸癌に対する術後補助化学療法の第III相試験(SACURA trial)におけるMSIと予後の検討
        石川 敏昭; 植竹 宏之; 石黒 めぐみ; 室谷 健太; 上野 秀樹; 松井 茂之; 中谷 英仁; 手良向 聡; 冨田 尚裕; 杉原 健一
        日本消化器外科学会総会, Jul. 2017
      • Stage II結腸癌におけるdesmoplastic reaction分類の臨床的意義 SACURA trialにおける前向き付随研究
        上野 秀樹; 石黒 めぐみ; 石川 敏昭; 中谷 英仁; 室谷 健太; 松井 茂之; 手良向 聡; 植竹 宏之; 冨田 尚裕; 杉原 健一
        日本消化器外科学会総会, Jul. 2017
      • わが国におけるStage II、III結腸癌に対する術後補助化学療法のバイオマーカー探索 SACURA trialとACTS-CC trialより
        植竹 宏之; 石川 敏昭; 石黒 めぐみ; 上野 秀樹; 松井 茂之; 室谷 健太; 中谷 英仁; 手良向 聡; 冨田 尚裕; 杉原 健一
        日本消化器外科学会総会, Jul. 2017
      • わが国におけるStage II、III結腸癌に対する術後補助化学療法のバイオマーカー探索 SACURA trialとACTS-CC trialより
        植竹 宏之; 石川 敏昭; 石黒 めぐみ; 上野 秀樹; 松井 茂之; 室谷 健太; 中谷 英仁; 手良向 聡; 冨田 尚裕; 杉原 健一
        日本消化器外科学会総会, Jul. 2017
      • Daple Coordinates Planar Polarized Microtubule Dynamics in Ependymal Cells and Contributes to Hydrocephalus
        Maki Takagishi; Masato Sawada; Shinya Ohata; Naoya Asai; Atsushi Enomoto; Kunihiko Takahashi; Liang Weng; Kaori Ushida; Hosne Ara; Shigeyuki Matsui; Kozo Kaibuchi; Kazunobu Sawamoto; Masahide Takahashi
        CELL REPORTS, Jul. 2017, Peer-reviewed
      • An efficient and flexible test for rare variant effects
        Shonosuke Sugasawa; Hisashi Noma; Takahiro Otani; Jo Nishino; Shigeyuki Matsui
        EUROPEAN JOURNAL OF HUMAN GENETICS, Jun. 2017, Peer-reviewed
      • Prognostic impact of tumor budding in stage II colon cancer: A prospective study (SACURA trial).
        Hideki Ueno; Megumi Ishiguro; Eiji Nakatani; Toshiaki Ishikawa; Hiroyuki Uetake; Kenta Murotani; Shigeyuki Matsui; Naohiro Tomita; Yasuhiro Shimada; Keiichi Takahashi; Kenjiro Kotake; Masahiko Watanabe; Hidetaka Mochizuki; Satoshi Teramukai; Kenichi Sugihara
        JOURNAL OF CLINICAL ONCOLOGY, May 2017
      • Prognostic impact of MSI in stage II colon cancers: An additional translational study of the SACURA trial.
        Toshiaki Ishikawa; Megumi Ishiguro; Eiji Nakatani; Hiroyuki Uetake; Hideki Ueno; Kenta Murotani; Shigeyuki Matsui; Naohiro Tomita; Yasuhiro Shimada; Keiichi Takahashi; Kenjiro Kotake; Masahiko Watanabe; Hidetaka Mochizuki; Satoshi Teramukai; Kenichi Sugihara
        JOURNAL OF CLINICAL ONCOLOGY, May 2017
      • A novel scoring system for predicting the neurologic prognosis prior to the initiation of induced hypothermia in cases of post-cardiac arrest syndrome: the CAST score
        Mitsuaki Nishikimi; Naoyuki Matsuda; Kota Matsui; Kunihiko Takahashi; Tadashi Ejima; Keibun Liu; Takayuki Ogura; Michiko Higashi; Hitoshi Umino; Go Makishi; Atsushi Numaguchi; Satoru Matsushima; Hideki Tokuyama; Mitsunobu Nakamura; Shigeyuki Matsui
        SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE, May 2017, Peer-reviewed
      • Quantifying indirect evidence in network meta-analysis
        Hisashi Noma; Shiro Tanaka; Shigeyuki Matsui; Andrea Cipriani; Toshi A. Furukawa
        STATISTICS IN MEDICINE, Mar. 2017, Peer-reviewed
      • Stae II結腸癌における再発リスクの層別と治療戦略の展望~SACURA trialの結果から
        石黒めぐみ; 上野秀樹; 石川敏昭; 中谷英仁; 手良向聡; 松井茂之; 室谷健太; 望月英隆; 固武健二郎; 高橋慶一; 渡邊昌彦; 島田安博; 冨田尚裕; 植竹宏之; 杉原健一; 石黒めぐみ; 上野秀樹; 石川敏昭; 中谷英仁; 手良向聡; 松井茂之; 室谷健太; 望月英隆; 固武健二郎; 高橋慶一; 渡邊昌彦; 島田安博; 冨田尚裕; 植竹宏之; 杉原健一
        日本臨床外科学会雑誌, 2017
      • Correcting Estimation Bias in Randomized Clinical Trials With a Test of Treatment-by-Biomarker Interaction
        Kiichiro Toyoizumi; Shigeyuki Matsui
        STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2017, Peer-reviewed
      • CAST: a new score for early prediction of neurological outcomes after cardiac arrest before therapeutic hypothermia with high accuracy
        Mitsuaki Nishikimi; Naoyuki Matsuda; Kota Matsui; Kunihiko Takahashi; Tadashi Ejima; Keibun Liu; Takayuki Ogura; Michiko Higashi; Hitoshi Umino; Go Makishi; Atsushi Numaguchi; Satoru Matsushima; Hideki Tokuyama; Mitsunobu Nakamura; Shigeyuki Matsui
        INTENSIVE CARE MEDICINE, Dec. 2016, Peer-reviewed
      • 消化器外科領域における最新のトランスレーショナルリサーチ Stage III結腸癌におけるDNAコピー数変化と無再発生存期間の関連 ACTS-CC試験のバイオマーカー探索
        石川 敏昭; 植竹 宏之; 石黒 めぐみ; 室谷 健太; 中谷 英仁; 小武内 尚; 松井 茂之; 杉原 健一
        日本消化器外科学会総会, Jul. 2016
      • 消化器外科領域における最新のトランスレーショナルリサーチ Stage III結腸癌におけるDNAコピー数変化と無再発生存期間の関連 ACTS-CC試験のバイオマーカー探索
        石川 敏昭; 植竹 宏之; 石黒 めぐみ; 室谷 健太; 中谷 英仁; 小武内 尚; 松井 茂之; 杉原 健一
        日本消化器外科学会総会, Jul. 2016
      • Association Between Photoreceptor Regeneration and Visual Acuity Following Surgery for Rhegmatogenous Retinal Detachment
        Misato Kobayashi; Takeshi Iwase; Kentaro Yamamoto; Eimei Ra; Kenta Murotani; Shigeyuki Matsui; Hiroko Terasaki
        INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, Mar. 2016, Peer-reviewed
      • Genome-wide DNA Copy-number Analysis in ACTS-CC Trial of Adjuvant Chemotherapy for Stage III Colonic Cancer
        Toshiaki Ishikawa; Hiroyuki Uetake; Kenta Murotani; Takashi Kobunai; Megumi Ishiguro; Shigeyuki Matsui; Kenichi Sugihara
        ANTICANCER RESEARCH, Mar. 2016, Peer-reviewed
      • Operative wound-related complications after cranial revascularization surgeries
        Keisuke Takanari; Yoshio Araki; Sho Okamoto; Hideyoshi Sato; Shunjiro Yagi; Kazuhiro Toriyama; Kinya Yokoyama; Kenta Murotani; Shigeyuki Matsui; Toshihiko Wakabayashi; Yuzuru Kamei
        JOURNAL OF NEUROSURGERY, Nov. 2015, Peer-reviewed
      • A comparative study of adaptive dose-finding designs for phase I oncology trials of combination therapies
        Akihiro Hirakawa; Nolan A. Wages; Hiroyuki Sato; Shigeyuki Matsui
        STATISTICS IN MEDICINE, Oct. 2015, Peer-reviewed
      • MSI, 18q LOH, and clinicopathological features in stage II sporadic colon cancers: Biomarker study in a phase III study of postoperative adjuvant chemotherapy for stage II colon cancer (SACURA trial)
        Toshiaki Ishikawa; Hiroyuki Uetake; Megumi Ishiguro; Kenta Murotani; Hideki Ueno; Shigeyuki Matsui; Kenichi Sugihara; Naohiro Tomita
        CANCER RESEARCH, Aug. 2015
      • 大腸腫瘍と遺伝・遺伝子 Stage II結腸癌術後補助化学療法の第III相試験(SACURA試験)におけるMSI・18qLOHと臨床病理学的因子の相関
        石川 敏昭; 植竹 宏之; 石黒 めぐみ; 室谷 健太; 上野 秀樹; 松井 茂之; 杉原 健一; 冨田 尚裕
        日本消化器外科学会総会, Jul. 2015
      • Sex-Related Differences in Ocular Blood Flow of Healthy Subjects Using Laser Speckle Flowgraphy
        Kosei Yanagida; Takeshi Iwase; Kentaro Yamamoto; Eimei Ra; Hiroki Kaneko; Kenta Murotani; Shigeyuki Matsui; Hiroko Terasaki
        INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, Jul. 2015, Peer-reviewed
      • Estimation of Treatment Effects in All-Comers Randomized Clinical Trials with a Predictive Marker
        Yuki Choai; Shigeyuki Matsui
        BIOMETRICS, Mar. 2015, Peer-reviewed
      • Operating characteristics of restrictions on skipping dose level for adaptive dose-finding method in two-agent phase I trials
        Hirakawa A; Matsui S
        Japanese Journal of Biometrics 2015, 2015
      • Idiopathic sudden sensorineural hearing loss in Japan.
        Nakashima T; Sato H; Gyo K; Hato N; Yoshida T; Shimono M; Teranishi M; Sone M; Fukunaga Y; Kobashi G; Takahashi K; Matsui S; Ogawa K
        Acta Otolaryngol, Nov. 2014, Peer-reviewed
      • Clinical Trials Express: Fracture Risk Reduction With Denosumab in Japanese Postmenopausal Women and Men With Osteoporosis: Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT)
        Toshitaka Nakamura; Toshio Matsumoto; Toshitsugu Sugimoto; Takayuki Hosoi; Takami Miki; Itsuo Gorai; Hideki Yoshikawa; Yoshiya Tanaka; Sakae Tanaka; Teruki Sone; Tetsuo Nakano; Masako Ito; Shigeyuki Matsui; Toshiyuki Yoneda; Hideo Takami; Ko Watanabe; Taisuke Osakabe; Masataka Shiraki; Masao Fukunaga
        JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, Jul. 2014
      • Comparison of Statistical Analysis Plans in Randomize-All Phase III Trials with a Predictive Biomarker
        Shigeyuki Matsui; Yuki Choai; Takahiro Nonaka
        CLINICAL CANCER RESEARCH, Jun. 2014
      • Response to letter to the editor by Dr Wages et al.
        Akihiro Hirakawa; Shigeyuki Matsui
        STATISTICS IN MEDICINE, May 2014
      • Nested case control study of proteomic biomarkers for interstitial lung disease in Japanese patients with non-small-cell lung cancer treated with erlotinib: A Multicenter phase IV study (JO21661)
        Shinji Atagi; Nobuyuki Katakami; Hiroshige Yoshioka; Masahiro Fukuoka; Shoji Kudoh; Atsushi Ogiwara; Masato Imai; Masamichi Ueda; Shigeyuki Matsui
        Clinical Lung Cancer, Jul. 2013
      • Empirical Bayes ranking and selection methods via semiparametric hierarchical mixture models in microarray studies
        Hisashi Noma; Shigeyuki Matsui
        STATISTICS IN MEDICINE, May 2013
      • PREDICTION OF PROGRESSION-FREE SURVIVAL IN PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR LOCALLY ADVANCED BLADDER CANCER USING A SNP PANEL OF CANCER-ASSOCIATED GENES
        Takamitsu Inoue; Shigeyuki Matsui; Norihiko Tsuchiya; Kazuyuki Numakura; Susumu Akihama; Mitsuru Saito; Shintaro Narita; Shigeru Satoh; Wun-Jae Kim; Tomonori Habuchi
        JOURNAL OF UROLOGY, Apr. 2013
      • Biomarker search using gene expression databases in a phase III, controlled clinical trial (ACTS-CC) of postoperative adjuvant chemotherapy for stage III colon cancer: Results of cluster analysis
        Hiroyuki Uetake; Toshiaki Ishikawa; Megimi Ishiguro; Kenta Murotani; Shigeyuki Matsui; Kenichi Sugihara
        CANCER RESEARCH, Apr. 2013
      • Meta-analysis of Oro-cecal Transit Time in Fasting Subjects
        Tohru Kokubo; Shigeyuki Matsui; Makio Ishiguro
        PHARMACEUTICAL RESEARCH, Feb. 2013
      • A dose finding approach based on shrunken predictive probability for combinations of two agents in phase I trials
        Hirakawa A; Hamada C; Matsui S
        Statistics in Medicine, 2013
      • Cancer Outlier Analysis Based on Mixture Modeling of Gene Expression Data
        Keita Mori; Tomonori Oura; Hisashi Noma; Shigeyuki Matsui
        COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2013
      • An empirical bayes optimal discovery procedure based on semiparametric hierarchical mixture models
        Hisashi Noma; Shigeyuki Matsui
        Computational and Mathematical Methods in Medicine, 2013
      • Genomic biomarkers for personalized medicine: Development and Validation in Clinical Studies
        Shigeyuki Matsui
        Computational and Mathematical Methods in Medicine, 2013
      • Distinct cancer-specific survival in metastatic prostate cancer patients classified by a panel of single nucleotide polymorphisms of cancer-associated genes.
        Tsuchiya N; Matsui S; Narita S; Kamba T; Mitsuzuka K; Hatakeyama S; Horikawa Y; Inoue T; Saito S; Ohyama C; Arai Y; Ogawa O; Habuchi T
        Genes Cancer, Jan. 2013
      • Developing and Validating Continuous Genomic Signatures in Randomized Clinical Trials for Predictive Medicine
        Shigeyuki Matsui; Richard Simon; Pingping Qu; John D. Shaughnessy; Bart Barlogie; John Crowley
        CLINICAL CANCER RESEARCH, Nov. 2012
      • Study protocol of the SACURA trial: a randomized phase III trial of efficacy and safety of UFT as adjuvant chemotherapy for stage II colon cancer
        Megumi Ishiguro; Hidetaka Mochizuki; Naohiro Tomita; Yasuhiro Shimada; Keiichi Takahashi; Kenjiro Kotake; Masahiko Watanabe; Yukihide Kanemitsu; Hideki Ueno; Toshiaki Ishikawa; Hiroyuki Uetake; Shigeyuki Matsui; Satoshi Teramukai; Kenichi Sugihara
        BMC CANCER, Jul. 2012
      • Involvement of urinary bladder Connexin43 and the circadian clock in coordination of diurnal micturition rhythm
        Hiromitsu Negoro; Akihiro Kanematsu; Masao Doi; Sylvia O. Suadicani; Masahiro Matsuo; Masaaki Imamura; Takeshi Okinami; Nobuyuki Nishikawa; Tomonori Oura; Shigeyuki Matsui; Kazuyuki Seo; Motomi Tainaka; Shoichi Urabe; Emi Kiyokage; Takeshi Todo; Hitoshi Okamura; Yasuhiko Tabata; Osamu Ogawa
        NATURE COMMUNICATIONS, May 2012
      • Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial
        Kentaro Sugano; Teiji Kontani; Shinichi Katsuo; Yoshinori Takei; Nobuhiro Sakaki; Kiyoshi Ashida; Yuji Mizokami; Masahiro Asaka; Shigeyuki Matsui; Tatsuya Kanto; Satoshi Soen; Tsutomu Takeuchi; Hideyuki Hiraishi; Naoki Hiramatsu
        JOURNAL OF GASTROENTEROLOGY, May 2012
      • Endoscopic evaluation of non-steroidal anti-inflammatory drug (NSAID)-induced gastric and duodenal ulcers during prophylaxis with lansoprazole
        Sakaki N; Ashida K; Mizokami Y; Asaka M; Matsui S; Kanto T; Hiraishi H; Hiramatsu N; Sugano K
        Journal of Gastroenterology and Hepatology Research, 2012
      • The optimal discovery procedure in multiple significance testing: an empirical Bayes approach
        Hisashi Noma; Shigeyuki Matsui
        STATISTICS IN MEDICINE, Jan. 2012
      • Estimating Effect Sizes of Differentially Expressed Genes for Power and Sample-Size Assessments in Microarray Experiments
        Shigeyuki Matsui; Hisashi Noma
        BIOMETRICS, Dec. 2011
      • 癌関連遺伝子SNPパネルを用いた転移性前立腺癌の予後予測(Prediction of survival in metastatic prostate cancer patients by SNP panel of cancer-associated genes)
        土谷 順彦; 松井 茂之; 成田 伸太郎; 神波 大己; 三塚 浩二; 畠山 真吾; 堀川 洋平; 井上 高光; 斎藤 誠一; 大山 力; 荒井 陽一; 小川 修; 羽渕 友則
        日本癌学会総会記事, Sep. 2011
      • Population pharmacokinetics of pregabalin in healthy subjects and patients with post-herpetic neuralgia or diabetic peripheral neuropathy
        Satoshi Shoji; Misaki Suzuki; Yoshiro Tomono; Howard N. Bockbrader; Shigeyuki Matsui
        BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, Jul. 2011
      • Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial
        Kentaro Sugano; Yasushi Matsumoto; Tsukasa Itabashi; Sumihisa Abe; Nobuhiro Sakaki; Kiyoshi Ashida; Yuji Mizokami; Tsutomu Chiba; Shigeyuki Matsui; Tatsuya Kanto; Kazuyuki Shimada; Shinichiro Uchiyama; Naomi Uemura; Naoki Hiramatsu
        JOURNAL OF GASTROENTEROLOGY, Jun. 2011
      • PREDICTION OF SURVIVAL IN METASTATIC PROSTATE CANCER PATIENTS BY SNP ARRAY ANALYSIS OF CANCER-ASSOCIATED GENES
        Norihiko Tsuchiya; Shigeyuki Matsui; Shintaro Narita; Takamitsu Inoue; Kazuyuki Numakura; Yohei Horikawa; Shingo Hatakeyama; Chikara Ohyama; Youichi Arai; Seiichi Saito; Osamu Ogawa; Tomonori Habuchi
        JOURNAL OF UROLOGY, Apr. 2011
      • Estimation and selection in high-dimensional genomic studies for developing molecular diagnostics
        Shigeyuki Matsui; Hisashi Noma
        BIOSTATISTICS, Apr. 2011
      • Medical mushrooms used for biochemical failure after radical treatment for prostate cancer: An open-label study
        Koji Yoshimura; Toshiyuki Kamoto; Osamu Ogawa; Shigeyuki Matsui; Norihiko Tsuchiya; Harue Tada; Keiko Murata; Kenichi Yoshimura; Tomonori Habuchi; Masanori Fukushima
        INTERNATIONAL JOURNAL OF UROLOGY, Jun. 2010
      • Bayesian ranking and selection methods using hierarchical mixture models in microarray studies
        Hisashi Noma; Shigeyuki Matsui; Takashi Omori; Tosiya Sato
        BIOSTATISTICS, Apr. 2010
      • Sorafenib efficacy in ovarian clear cell carcinoma revealed by transcriptome profiling
        N. Matsumura; M. Mandai; T. Okamoto; K. Yamaguchi; T. Oura; T. Baba; S. Mori; S. Murphy; I. Konishi
        GYNECOLOGIC ONCOLOGY, Mar. 2010
      • Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes
        K. Yamaguchi; M. Mandai; T. Oura; N. Matsumura; J. Hamanishi; T. Baba; S. Matsui; S. K. Murphy; I. Konishi
        ONCOGENE, Mar. 2010
      • Optimality of gene ranking based on univariate P-values for detecting differentially expressed genes
        Noma H; Matsui S
        Japanese Journal of Biometrics, 2010
      • Gene signature specific for ovarian clear cell carcinoma is induced by the contents of endometriotic cysts
        K. Yamaguchi; M. Mandai; N. Matsumura; T. Baba; T. Oura; S. Matsui; S. K. Murphy; A. Berchuck; S. Fujii; I. Konishi
        GYNECOLOGIC ONCOLOGY, Feb. 2009
      • Sample sizes for a robust ranking and selection of genes in microarray experiments.
        Matsui S; Oura T
        Statistics in Medicine, 2009
      • Sample size calculations for controlling the distribution of false discovery proportion in microarray experiments.
        Oura T; Matsui S; Kawakami K
        Biostatistics, 2009
      • Long-Term Probucol Treatment Prevents Secondary Cardiovascular Events: a Cohort Study of Patients with Heterozygous Familial Hypercholesterolemia in Japan
        Shizuya Yamashita; Hideaki Bujo; Hidenori Arai; Mariko Harada-Shiba; Shigeyuki Matsui; Masanori Fukushima; Yasushi Saito; Toru Kita; Yuji Matsuzawa
        JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, Dec. 2008
      • Overview of the clinical application of regenerative medicine products in Japan
        Mina Tsubouchi; Shigeyuki Matsui; Yoshiro Banno; Kiyoshi Kurokawa; Koji Kawakami
        HEALTH POLICY, Oct. 2008
      • Critical issues for effective collaboration between academia and industry in the field of regenerative medicine in Japan
        Mina Tsubouchi; Ryuichi Moishita; Yasuhiko Tabata; Sbigeyuki Matsui; Koji Kawakami
        REGENERATIVE MEDICINE, Jul. 2008
      • Efficacy, toxicity and cost analysis for non-platinum triplet (gemcitabine and vinorelbine, followed by docetaxel) vs. platinum-based chemotherapy in IIIB/IV non-small-cell lung cancer: single-institution experience
        H. Tada; S. Matsui; M. Kawahara; S. Hosoe; C. Hamada; M. Fukushima
        EUROPEAN JOURNAL OF CANCER CARE, Mar. 2008
      • Sample size calculations based on ranking and selection in microarray experiments
        Shigeyuki Matsui; Shu Zeng; Takeharu Yamanaka; John Shaughnessy
        BIOMETRICS, Mar. 2008
      • Clustering of significant genes in prognostic studies with microarrays: Application to a clinical study for multiple myeloma
        Shigeyuki Matsui; Takeharu Yamanaka; Bart Barlogie; John D. Shaughnessy; John Crowley
        STATISTICS IN MEDICINE, Mar. 2008
      • P21-activated kinase 1: A new molecular marker for intravesical recurrence after transurethral resection of bladder cancer
        Masaaki Ito; Hiroyuki Nishiyama; Hiroaki Kawanishi; Shigeyuki Matsui; Parry Guilford; Anthony Reeve; Osamu Ogawa
        JOURNAL OF UROLOGY, Sep. 2007
      • Genomic characterization of multiple clinical phenotypes of cancer using multivariate linear regression models
        Shigeyuki Matsui; Masaaki Ito; Hiroyuki Nishiyama; Hajime Uno; Hirokazu Kotani; Jun Watanabe; Parry Guilford; Anthony Reeve; Masanori Fukushima; Osamu Ogawa
        BIOINFORMATICS, Mar. 2007
      • Lessons from gefitinib-induced interstitial lung disease in Japan: Problems in approval, pharmacovigilance, and regulatory decision-making procedures.
        Tsutomu Nishimura; Harue Tada; Masatsugu Nakagawa; Satoshi Teramukai; Shigeyuki Matsui; Masanori Fukushima
        Pharmacy practice, Oct. 2006
      • 癌臨床試験を支援する機構のあり方 臨床研究情報センター(TRI)の役割
        松山 琴音; 永井 洋士; 稲岡 正子; 手良向 聡; 松井 茂之; 福島 雅典; 村上 雅義
        日本癌治療学会誌, Sep. 2006
      • Predicting survival outcomes using subsets of significant genes in prognostic marker studies with microarrays
        Shigeyuki Matsui
        BMC BIOINFORMATICS, Mar. 2006
      • Reducing false positive findings in statistical analysis of pharmacogenomic biomarker studies using high-throughput technologies
        Matsui S
        Current Drug Safety2006, 2006
      • Erythropoietin as a retinal angiogenic factor
        P Manzoni; A Maestri; G Gomirato
        NEW ENGLAND JOURNAL OF MEDICINE, Nov. 2005
      • Stratified analysis in randomized trials with noncompliance
        S Matsui
        BIOMETRICS, Sep. 2005
      • Sample size calculations for comparative clinical trials with over-dispersed Poisson process data
        S Matsui
        STATISTICS IN MEDICINE, May 2005
      • Prognostic factor analysis for plaque psoriasis
        R Sakai; S Matsui; M Fukushima; H Yasuda; H Miyauchi; Y Miyachi
        DERMATOLOGY, 2005
      • Creutzfeldt-Jakob disease and cadaveric dura mater grafts in Japan: An updated analysis of incubation time
        S Matsui; T Sadaike; C Hamada; M Fukushima
        NEUROEPIDEMIOLOGY, 2005
      • 何がエンドポイントか エンドポイントの臨床的・統計的論点
        小田 英世; 山中 竹春; 大門 貴志; 手良向 聡; 松井 茂之; 福島 雅典
        薬剤疫学, Nov. 2004
      • 日本の多施設共同研究の現況と今後 臨床試験における統計家の役割-プロトコル作成から報告まで
        手良向 聡; 小田 英世; 大門 貴志; 福永 至宏; 松井 茂之
        小児がん, Nov. 2004
      • 全国規模の肺癌外科手術例のアウトカム評価 94年と98年の病理病期別5年生存率について
        横山 奈緒美; 小野寺 理恵; 多田 春江; 中川 正嗣; 松井 茂之; 手良向 聡; 福島 雅典; 肺癌外科アウトカム評価グループ
        肺癌, Oct. 2004
      • 【再生医療による心臓病治療の最前線 基礎と臨床】再生医療における臨床試験のあり方
        福島 雅典; 手良向 聡; 小島 伸介; 小野寺 理恵; 松井 茂之; 小田 英世
        Cardiovascular Med-Surg, Aug. 2004
      • 日本の多施設共同研究の現況と今後 臨床試験における統計家の役割 プロトコル作成から報告まで
        手良向 聡; 小田 英世; 大門 貴志; 福永 至宏; 松井 茂之
        日本小児血液学会雑誌, Aug. 2004
      • Analysis of times to repeated events in two-arm randomized trials with noncompliance and early withdrawal
        Matsui S
        Biometrics, 2004, Peer-reviewed
      • Functional assessment of self-renewal activity of male germline stem cells following cytotoxic damage and serial transplantation
        M Kanatsu-Shinohara; S Toyokuni; T Morimoto; S Matsui; T Honjo; T Shinohara
        BIOLOGY OF REPRODUCTION, May 2003
      • 中間解析におけるベイズ流アプローチ:最近の理論的展開
        宇野一; 松井茂之; 小山暢之
        計量生物学, 2000
      • 中間解析における頻度論的アプローチ:最近の理論的展開
        松井茂之; 宇野一; 小山暢之
        計量生物学, 2000
      • Design of clinical trials for recurrent events with periodic monitoring
        S Matsui; H Miyagishi
        STATISTICS IN MEDICINE, Nov. 1999
      • Analysis of recurrent events: Application to a clinical trial of colony stimulating factor with the endpoint of febrile neutropenia
        S Matsui; Y Ohashi
        STATISTICS IN MEDICINE, Sep. 1999

      Presentations

      • AI医療技術の検証に向けて:現状と課題
        松井茂之
        IBISML, 18 Jan. 2021, 電子情報通信学会, Invited
      • 医療健康データサイエンティスト:次代の担い手の育成について
        松井茂之
        統計数理研究所医療健康データ科学研究センターシンポジウム, 05 Nov. 2020, 統計数理研究所, Invited
      • 脳画像を用いた疾患関連解析における神経学的,機能的領域を考慮した多重検定
        江本 遼; 松井茂之
        2020年度 統計関連学会連合大会, 12 Sep. 2020, 統計関連学会連合
      • 重み付き尤度関数を用いた治療効果のバイアス補正
        豊泉樹一郎; 松井茂之
        2020年度 統計関連学会連合大会, 12 Sep. 2020, 統計関連学会連合
      • Incorporating follow-up lengths in sample size re-estimation to compare over-dispersed count data
        Masataka Igeta; Shigeyuki Matsui
        ISCB 2020, 25 Aug. 2020, International Society of Clinical Biostatistics
      • Multiple Testing and Estimation of Disease Associations Based on Semi-Parametric Hierarchical Mixture Models, Possibly Incorporating Brain Areas
        Ryo Emoto; Takahiro Otani; Shigeyuki Matsui
        Eastern North American Region International Biometric Society, 2019 Meeting, 24 Mar. 2019
      • Blinded Sample Size Re-estimation in Comparative Clinical Trials with Over-Dispersed Count Data: Incorporation of Misspecification of the Variance Function.
        Masataka Igeta; Shigeyuki Matsui
        Eastern North American Region International Biometric Society, 2019 Meeting, 24 Mar. 2019
      • 単変量Cox回帰にもとづく遺伝子選択と複合共変量による生存期間の予測
        江村剛志; 松井 茂之; Hsuan-Yu Chen
        2018年度統計関連学会連合大会, 10 Sep. 2018
      • 脳画像を用いた疾患関連解析における効果サイズ推定
        江本 遼; 川口 淳; 松井茂之
        2018年度統計関連学会連合大会, 10 Sep. 2018
      • 生物・医学分野の新たな展開:データを中心とした拡がり/繋がり
        松井茂之
        2018年度統計関連学会連合大会日本計量生物学会シンポジウム, 10 Sep. 2018, 日本計量生物学会, Invited
      • Bias-Corrected Estimation of Treatment Effects in Biomarker-Based Adaptive Subgroup Analysis: New Approach Based on Randomized Tests with Smooth Rejection Function
        Kiichiro Toyoizumi; Shigeyuki Matsui
        Joint Statistical Meeting 2019, 28 Jul. 2018
      • Hierarchical Mixture Modeling for Multiple Testing and Effect Size Estimation in Voxel-Level Inference of Neuroimaging Data.
        Ryo Emoto; Atsushi Kawaguchi; Hisako Yoshida; Shigeyuki Matsui
        Joint Statistical Meeting 2019, 28 Jul. 2018
      • A Transfer Learning Method for Multi-Center Prognostic Prediction Analysis.
        Kota Matsui; Kenta Kanamori; Wataru Kumagai; Mitsuaki Nishikimi; Shigeyuki Matsui
        3rd International Workshop on Biomedical Informatics with Optimization and Machine Learning in conjunction with 27th International Joint Conference on Artificial Intelligence, 13 Jul. 2018
      • Two-Stage Analysis for Selecting Fixed Numbers of Features in Omics Association Studies
        Takanori Kawabata; Ryo Emoto; Jo Nishino; Kunihiko Takahashi; Shigeyuki Matsui
        XXIX International Biometric Conference, 12 Jul. 2018
      • Phase III Clinical Trial Design for Targeted Therapies with Uncertain Biomarker Evidence: Controversies and Solutions (Keynote).
        Matsui S
        OHSU Cancer Biostatistics Workshop, 24 May 2018, Invited
      • Omics 研究における検証的解析と探索的解析
        佐藤 俊哉; 三中 信宏; 松井茂之; 寒水 孝司
        2017 年度統計関連学会連合大会日本計量生物学会シンポジウム, 04 Sep. 2017, Invited
      • セミパラメトリック階層混合モデルによる複雑疾患GWASの解析
        西野 穣; 高地 雄太; 重水 大智; 加藤 護; 猪狩 勝則; 越智 秀典; 野間 久史; 松井 孝太; 大谷隆浩; 森園 隆; 松井茂之
        第27回 日本疫学会学術総会, 25 Jan. 2017
      • セミパラメトリック階層混合モデルによる複雑疾患の遺伝的構造の推定と集団遺伝学的考察
        西野 穣; 松井茂之
        統計数理研究所公募型共同研究重点テーマ2:次世代への健康科学共通公開研究集会, 25 Aug. 2016
      • Stage III結腸癌におけるDNAコピー数変化と無再発生存期間の関連~ACTS-CC試験のバイオマーカー探索
        石川敏昭; 植竹宏之; 石黒めぐみ; 室谷健太; 中谷英仁; 小武内尚; 松井茂之; 杉原健
        第71回日本消化器外科学会総会, 14 Jul. 2016
      • A comparison of multiple testing methods for effective strategies in genome-wide association studies
        Otani T; Noma H; Nishino J; Matsui K; Matsui S
        XXVIIIth International Biometric Conference, 10 Jul. 2016
      • Cancer Outlier Analysis Based on a Nested Two-Way Clustering
        Oura T; Matsui K; Matsui S
        XXVIIIth International Biometric Conference, 10 Jul. 2016
      • ゲノムワイド関連解析データを用いた複雑疾患の階層混合モデル解析
        西野穣; 高地雄太; 野間久史; 重水大智; 森園隆; 角田達彦; 松井茂之
        2015年度統計関連学会連合大会, 06 Sep. 2015
      • 予測マーカーと治療の交互作用検定を用いるランダム化臨床試験における治療効果のバイアス補正
        豊泉樹一郎; 松井茂之
        2015年度統計関連学会連合大会, 06 Sep. 2015
      • Biomarker-based all-comers phase III trials: design issues and solutions
        Matsui S
        The first Pacific Rim Cancer Biostatistics Conference, 14 Aug. 2015
      • Bias-corrected estimation of treatment effects in biomarker-based randomized clinical trials
        Toyoizumi K; Matsui S
        Joint Statistical Meetings 2015, 11 Aug. 2015
      • MSI, 18q LOH, and clinicopathological features in stage II sporadic colon cancers: Biomarker study in a Phase III Study of Postoperative Adjuvant Chemotherapy for Stage II Colon Cancer (SACURA trial)
        Ishikawa T; Uetake H; Ishiguro M; Murotani K; Matsui S; Ueno H; Sugihara K; Tomita N; SACURA study group
        第70回日本消化器外科学会総会, 15 Jul. 2015
      • ACTS-CC study group. CT211 biomarker search using gene expression databases in a phase III, controlled clinical trial of postoperative adjuvant chemotherapy for stage III colon cancer (ACTS-CC): correlation between clinicopathological factors and gene expression level
        Uetake H; Ishikawa T; Ishiguro M; Matsui S; Sugihara K; ACTS-CC study group
        American Association for Cancer Research Annual Meeting 2015, 22 Apr. 2015
      • MSI, 18qLOH, and clinicopathologicalfeatures in stage II sporadic colon cancers: Biomarker study in a phase III study of postoperative adjuvantchemotherapyfor stage II colon cancer (SACURA trial)
        Ishikawa T; Uetake H; Ishiguro M; Murotani K; Matsui S; Ueno H; Sugihara K; Tomita N; SACURA study group
        American Association for Cancer Research Annual Meeting 2015, 22 Apr. 2015
      • ACTS-CC study group. CT211 biomarker search using gene expression databases in a phase III, controlled clinical trial of postoperative adjuvant chemotherapy for stage III colon cancer (ACTS-CC): correlation between clinicopathological factors and gene exp
        Uetake H; Ishikawa T; Ishiguro M; Matsui S; Sugihara K; ACTS-CC study group
        American Association for Cancer Research Annual Meeting 2015, 22 Apr. 2015
      • 計量生物学の更なる可能性を求めて
        松井茂之
        2014 年度日本計量生物学会賞受賞者講演, 12 Mar. 2015
      • Statistical analysis plans in phase III all-comers clinical trials with a predictive biomarker
        Matsui S
        The XXVII International Biometric Conference, 06 Jul. 2014

      Books and Other Publications

      • 臨床試験の事典
        丹後, 俊郎; 松井, 茂之
        朝倉書店, Jan. 2023
      • Biomarker-based phase II and III clinical trials in oncology.
        Matsui S; Igeta M; Toyoizumi K, Joint work
        CRC Press, 2019
      • Survival Analysis with Correlated Endpoints: Joint Frailty-Copula Models
        Emura T; Chen YH; Matsui S; Rondeau V, Joint work
        Springer, 2019
      • Dose-Finding Designs for Early-Phase Cancer Clinical Trials: A Brief Guidebook to Theory and Practice
        Daimon T; Hirakawa A; Matsui S, Joint work
        Springer, 2019
      • Modern Dose-Finding Designs for Cancer Phase I Trials: Drug Combination and Molecularly Targeted Agents.
        Hirakawa A; Sato H; Daimon T; Matsui S, Joint work
        Springer, 2018, Not refereed
      • 新版医学統計学ハンドブック
        丹後俊郎; 松井茂之, Joint work
        朝倉書店, 2018, Not refereed
      • Frontiers of Biostatistical Methods and Applications in Clinical Oncology.
        Matsui S; Crowley J, Joint work
        Springer, 17 Oct. 2017, Not refereed
      • Univariate analysis for gene screening: beyond the multiple testing
        Noma H; Matsui S, Joint work
        CRC, 19 Mar. 2015, Not refereed
      • Statistical issues in clinical development and validation of genomic signatures
        Matsui S, Single work
        CRC, 19 Mar. 2015, Not refereed
      • Phase III all-comers clinical trials with a predictive biomarker
        Matsui S; Choai Y; Nonaka T, Joint work
        CRC, 19 Mar. 2015, Not refereed
      • Phase I dose-finding designs and their applicability to targeted therapies
        Daimon T; Hirakawa A; Matsui S, Joint work
        CRC, 19 Mar. 2015, Not refereed
      • Clinical trials for predictive medicine: new paradigms and challenges. In Design and Analysis of Clinical Trials for Predictive Medicine
        Simon R; Matsui S; Buyse M, Joint work
        CRC, 19 Mar. 2015, Not refereed
      • Design and Analysis of Clinical Trials for Predictive Medicine
        Matsui S; Buyse M; Simon R, Joint work
        CRC, 19 Mar. 2015, Not refereed
      • Developments in Statistical Evaluation of Clinical Trials
        Hirakawa A; Matsui S, Joint work
        Springer, 2014, Not refereed
      • Developments in Statistical Evaluation of Clinical Trials
        Matsui S; Nonaka T; Choai Y, Joint work
        Springer, 2014, Not refereed
      • Handbook of Statistics in Clinical Oncology, 3rd edn. (eds JJ. Crowley and A Hoering)
        Matsui S; Noma H, Single work
        CRC Press, 2012, Not refereed
      • Handbook of Statistics in Clinical Oncology, 2nd edn. (eds J.J. Crowley and D.P. Ankerst)
        Matsui S, Single work
        CRC Press, 2006, Not refereed
      • 臨床試験ハンドブック
        松井茂之, Single work
        朝倉書店, 2006, Not refereed

      Works

      • がん第 I 相試験における 2 剤併用療法の用量探索法:最近の展開
        From 2014
      • 「臨床試験結果の公開は倫理的、科学的に重要」
        From 2014

      External funds: Kakenhi

      • Statistical evaluation of rare diseases based on individual patient-level data analysis
        Grant-in-Aid for Scientific Research (A)
        Medium-sized Section 60:Information science, computer engineering, and related fields
        Kyoto University
        松井 茂之
        From 01 Apr. 2026, To 31 Mar. 2030, Granted
        統計科学
      • 統計的仮説検定への依存度を減らした仮説検証のための実験計画
        Grant-in-Aid for Challenging Research (Exploratory)
        Medium-sized Section 60:Information science, computer engineering, and related fields
        Kyoto University
        松井 茂之
        From 27 Jun. 2025, To 31 Mar. 2027, Granted
        統計科学;実験的研究;統計的仮説検定
      • Use of deep learning and development of statistical prediction result evaluation methods for the acceleration of personalized medicine
        Grant-in-Aid for Scientific Research (C)
        Basic Section 60030:Statistical science-related
        Teikyo University
        松浦 正明
        From 01 Apr. 2023, To 31 Mar. 2026, Granted
        統計学;予測問題;個別化医療;深層学習;バイオインフォマティクス;遺伝子
      • Research on statistical and machine learning methods to support adaptive clinical studies in personalized medicine
        Grant-in-Aid for Scientific Research (A)
        Medium-sized Section 60:Information science, computer engineering, and related fields
        Nagoya University
        Shigeyuki Matsui
        From 05 Apr. 2021, To 31 Mar. 2025, Project Closed
        統計科学;臨床研究;因果推論;予測解析;小標本;個別化医療;機械学習;選択的推論
      • Development of statistical evaluation method for artificial intelligence and deep learning for personalized medicine
        Grant-in-Aid for Scientific Research (B)
        Basic Section 12040:Applied mathematics and statistics-related
        Teikyo University
        Masaaki Matsuura
        From 01 Apr. 2019, To 31 Mar. 2022, Project Closed
        統計;個別化医療;人口知能;深層学習;データ解析;データサイエンス;疫学;統計学;人工知能
      • A new framework of discrimination analysis for high-dimensional data based on estimation of data structure
        Grant-in-Aid for Challenging Exploratory Research
        Nagoya University
        Shigeyuki Matsui
        From 01 Apr. 2016, To 31 Mar. 2019, Project Closed
        判別・予測解析;機械学習;疾患の異質性;統計モデリング;統計科学;構造推定;判別解析;階層混合モデル;統計的判別解析;疾患異質性;高次元データ;疾患の遺伝的異質性;数理工学;生物統計学
      • Comprehensive research on statistical methodologies and their applications for development of personalized medicine
        Grant-in-Aid for Scientific Research (S)
        Nagoya University
        Shigeyuki Matsui
        From 31 May 2016, To 31 Mar. 2021, Project Closed
        統計科学;生物統計学;機械学習;個別化医療;臨床研究;研究デザイン;データ解析;社会医学;薬剤反応性;臨床試験;統計解析;診断法開発;統計数学
      • Development of statistical methods based on omics data for realizing predictive medicine
        Grant-in-Aid for Scientific Research (B)
        Teikyo University
        Masaaki Matsuura
        From 01 Apr. 2015, To 31 Mar. 2019, Project Closed
        統計;オミックスデータ;バイオマーカー;データ解析;不均一性;統計学;オミクスデータ;ビッグデータ
      • Integration of spatial epidemiology and pharmacoepidemiology for the practical use of the adverse drug event report database with related applications
        Grant-in-Aid for Challenging Exploratory Research
        Nagoya University
        Kunihiko Takahashi
        From 01 Apr. 2014, To 31 Mar. 2017, Project Closed
        空間疫学;薬剤疫学;副作用;自発報告;集積性;疾病集積性;クラスタリング;シグナル検出;有害事象;集積性検出
      • Statistical methodology for stabilizing of the genome-omics data analysis
        Grant-in-Aid for Scientific Research (B)
        The Institute of Statistical Mathematics
        Shinto Egichi
        From 01 Apr. 2013, To 31 Mar. 2018, Project Closed
        オミクス データ;遺伝子ランキング;データ異質性;高次元・小標本;準線形モデル;表現型予測;非線形予測;準線形回帰モデル;拡散テンソル画像;一般化平均;遺伝子発現;クラスター;乳がんデータ;ベキエントロピー;ゲノムワイド探索;遺伝子発現データ;群判別問題;ガンマ・K-平均;ロバスト クラスタリング;メタラーニング;Itakura-Saitoダイバージェンス;特徴ベクトル;2群判別問題;線形判別;ブースティング法;符号和統計量;個人化治療;効果予測
      • Design and statistical analysis in translational clinical trials
        Grant-in-Aid for Scientific Research (A)
        Nagoya University;The Institute of Statistical Mathematics
        Shigeyuki Matsui
        From 01 Apr. 2012, To 31 Mar. 2016, Project Closed
        臨床試験;統計的デザイン;データ解析;個別化医療;先端医療技術;臨床試験の計画と解析;先端医療技術の開発;診断法開発;ゲノムデータの解析;ゲノムデータ解析;統計解析;バイオマーカー;予測解析
      • Design and analysis of clinical studies for personalized medicine
        Grant-in-Aid for Scientific Research (C)
        The Institute of Statistical Mathematics
        Shigeyuki MATSUI
        From 01 Apr. 2008, To 31 Mar. 2011, Project Closed
        医学統計;ゲノム薬理学;個別化医療;ゲノムワイド研究;分子診断法の開発;マイクロアレー;臨床研究の計画と解析;階層混合モデル;遺伝子スクリーニング;体外診断法の開発;ベイズ流階層混合モデル
      • The research to establish the recurrence predicting system for hepatocellular carcinoma patients by use of genome-wide microarray database and to identify therapeutic molecular targets
        Grant-in-Aid for Scientific Research (B)
        Kyoto University
        Seiji SATOH
        From 01 Apr. 2004, To 31 Mar. 2006, Project Closed
        肝細胞癌;β-カテニン;マイクロアレイ;TaqMan PCR;LOH;再発;SIAH1;PEG10;定量的RT-PCR, Hepatocellular carcinoma;β-atenin;cDNA microarray;TaqMan PCR;LOH;Recurrence;SIAH1;PEG10
      • The relationship of the consciousness and behavior towards sex and reproduction and psychosocial variable -Determinants of decrease of the unintended pregnancy and abortion-
        Grant-in-Aid for Scientific Research (C)
        KURUME UNIVERSITY;Oita University of Nursing and Health Sciences
        Masako MIZOGUCHI
        From 01 Apr. 2000, To 31 Mar. 2003, Project Closed
        望まない妊娠;中絶;心理社会的変数;未婚者(大学生);既婚者;性及び生殖に対する態度, unintended pregnancy;abortion;psychosocial variable;students;married of the reproduction age;attitudes toward sex and reproduction
      • 再起的事象を対象とした臨床試験における中間解析に関する研究
        Grant-in-Aid for Encouragement of Young Scientists (A)
        Oita University of Nursing and Health Sciences
        松井 茂之
        From 01 Apr. 1999, To 31 Mar. 2001, Project Closed
        再起的事象;臨床試験;中間解析
      list
        Last Updated :2026/08/21

        Education

        Teaching subject(s)

        • From 01 Apr. 2026, To 31 Mar. 2027
          Methods of Data Analysis
          M348, Fall, Institute for Liberal Arts and Sciences, 2
        • From 01 Apr. 2026, To 31 Mar. 2027
          Biomedical Data Science
          M347, Spring, Institute for Liberal Arts and Sciences, 2
        • From 01 Apr. 2026, To 31 Mar. 2027
          Introduction to clinical research and clinical development
          3233, Fall, Faculty of Medicine, 1
        • From 01 Apr. 2026, To 31 Mar. 2027
          Practice of Clinical Biostatistics-2
          H187, Fall, Graduate School of Medicine, 1
        • From 01 Apr. 2026, To 31 Mar. 2027
          Practice of Data Analysis
          H183, Fall, Graduate School of Medicine, 1
        • From 01 Apr. 2026, To 31 Mar. 2027
          Practicum in Fundamentals of Statistical Inference
          H144, Spring, Graduate School of Medicine, 1
        • From 01 Apr. 2026, To 31 Mar. 2027
          Statistical Modeling and Applications
          H138, Fall, Graduate School of Medicine, 1
        • From 01 Apr. 2026, To 31 Mar. 2027
          Practice of Clinical Biostatistics
          H186, Spring, Graduate School of Medicine, 1
        • From 01 Apr. 2026, To 31 Mar. 2027
          Introduction to Machine Learning
          H185, Spring, Graduate School of Medicine, 1
        • From 01 Apr. 2026, To 31 Mar. 2027
          Biomedical Data Science
          H184, Spring, Graduate School of Medicine, 1
        • From 01 Apr. 2026, To 31 Mar. 2027
          Survival Analysis
          H137, Fall, Graduate School of Medicine, 1
        • From 01 Apr. 2026, To 31 Mar. 2027
          Statistical Methods in Clinical Trials
          H135, Fall, Graduate School of Medicine, 1
        • From 01 Apr. 2026, To 31 Mar. 2027
          Methods of Data Analysis
          H176, Fall, Graduate School of Medicine, 2
        • From 01 Apr. 2026, To 31 Mar. 2027
          Biomedical Data Science
          H174, Spring, Graduate School of Medicine, 2
        • From 01 Apr. 2026, To 31 Mar. 2027
          Clinical Research Training II
          H147, Year-long, Graduate School of Medicine, 2
        • From 01 Apr. 2026, To 31 Mar. 2027
          Clinical Research Training I
          H140, Year-long, Graduate School of Medicine, 2
        • From 01 Apr. 2026, To 31 Mar. 2027
          Fundamentals of Statistical Inference
          H136, Spring, Graduate School of Medicine, 2
        • From 01 Apr. 2026, To 31 Mar. 2027
          Health Policy and Academia
          H127, Spring, Graduate School of Medicine, 2
        • From 01 Apr. 2025, To 31 Mar. 2026
          Multiplicity in clinical trials
          H145, Spring, Graduate School of Medicine, 1
        • From 01 Apr. 2025, To 31 Mar. 2026
          Statisticians Standard of Conducts
          H134, Spring, Graduate School of Medicine, 1
        • From 01 Apr. 2025, To 31 Mar. 2026
          Health Data Processing Laboratory
          H022, Fall, Graduate School of Medicine, 2
        • From 01 Apr. 2025, To 31 Mar. 2026
          Methods of Data Analysis
          H176, Fall, Graduate School of Medicine, 2
        • From 01 Apr. 2025, To 31 Mar. 2026
          Practice of Biomedical Data Science
          H175, Spring, Graduate School of Medicine, 2
        • From 01 Apr. 2025, To 31 Mar. 2026
          Biomedical Data Science
          H174, Spring, Graduate School of Medicine, 2

        Participation in PhD Defense

        • Screening-Detected Atrial Fibrillation and Cardiovascular Outcomes in Working-Age Adults
          MORI YUICHIRO, Graduate School of Medicine, Sub-chief Examiner
          23 Mar. 2026
        • Development and Validation of a Claims-Based Algorithm for Identifying Incident Colorectal Cancer and Determining Progression Phases
          AGATSUMA NOBUKAZU, Graduate School of Medicine, Sub-chief Examiner
          23 Mar. 2026
        • Enhancement of the left frontoparietal network through real-time functional magnetic resonance imaging functional connectivity-informed neurofeedback and its impact on working memory in schizophrenia: A pilot study
          KOBAYASHI YUKO, Graduate School of Medicine, Sub-chief Examiner
          23 Jan. 2026
        • Development of interpretable machine learning models to predict in‐hospital prognosis of acute heart failure patients
          TANAKA MUNEKAZU, Graduate School of Medicine, Sub-chief Examiner
          23 Mar. 2026
        • Joint Analysis of Two Time-to-Event Outcomes Using a Product Partition Model Accounting for Semi-competing Risks
          LEI KANG, Graduate School of Medicine, Chief Examiner
          25 Nov. 2025
        • Sex-specific clinical course of young patients with Brugada syndrome
          IMAMURA TOMOHIKO, Graduate School of Medicine, Sub-chief Examiner
          25 Nov. 2025
        list
          Last Updated :2026/08/21

          Administration

          School management (title, position)

          • From 01 Apr. 2024, To 31 Mar. 2026
            臨床研究審査委員会 委員
          • From 01 Apr. 2024, To 31 Mar. 2026
            特定認定再生医療等委員会 委員

          Faculty management (title, position)

          • From 01 Apr. 2026, To 31 Mar. 2028
            学術情報システム・情報セキュリティ委員会_委員
          • From 01 Apr. 2025, To 31 Mar. 2027
            医療DX教育研究センター運営委員会_委員

          ページ上部へ戻る